Multi-component stent-graft system for aortic dissections

Description

FIELD OF THE APPLICATION

The present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular grafts and stent-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating dissections of arterial walls and/or aneurysms.

BACKGROUND OF THE APPLICATION

Blood vessels occasionally weaken or even rupture. For example, in the aortic artery, the vascular wall can weaken or tear, resulting in dangerous conditions such as aneurysm and dissection. Treatment of such conditions can be performed by implanting a prosthesis within the vascular system using minimally-invasive surgical procedures. An endoluminal prosthesis typically includes one or more stents affixed to graft material and is delivered to the treatment site by endovascular insertion. Once the endoluminal prosthesis is radially enlarged, it should remain in place indefinitely by self-attachment to the vessel wall, acting as a substitute vessel for the flow of blood or other fluids.

Aortic dissection is a tear or partial tear in the inner wall of the aorta, which causes blood to flow between the layers of the wall of the aorta, forcing the layers apart. Aortic dissections may be divided into two types in accordance with the Stanford classification: Type A dissections involve the ascending aorta and/or aortic arch, and possibly the descending aorta. Type B dissections involves the descending aorta or the arch (distal to right brachiocephalic artery origin), without involvement of the ascending aorta.

SUMMARY OF THE APPLICATION

In some applications of the present invention, a multi-component stent-graft system is provided for treating a Type B aortic dissection. The system is configured to be deployed in the thoracic aorta and the left subclavian artery, and, optionally, the left common carotid artery. The stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent-grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex. Typically, upon deployment, the multi-component stent-graft system defines a blood-flow path from the ascending aorta, over the aortic arch, and to the descending aorta. The multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.

The multi-component stent-graft system comprises a main module and, for some applications, a secondary module. The main module comprises a generally tubular main stent-graft, and the secondary module comprises a non-bifurcated secondary stent-graft. The stent-grafts are configured to assume radially-compressed states for delivery, and radially-expanded states upon being deployed.

The main stent-graft typically comprises a main generally tubular support element and a main covering element that is attached to and at least partially covers the main support element. The support element typically comprises a plurality of main structural stent elements. For some applications, the main structural stent elements are arranged as a plurality of circumferential stent springs.

The main covering element and the main support element are shaped so as to together define a lateral fenestration, e.g., exactly one lateral fenestration, through the main stent-graft, when the main stent-graft is unconstrained in its radially-expanded state.

For some applications, when the main stent-graft is unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise, a first perimeter of a distal main-module end of the main stent-graft (and the main module) is greater than a second perimeter of a proximal main-module end of the main stent-graft (and the main module). For example, the first perimeter may equal at least 150% of the second perimeter, such as at least 200%, at least 250%, at least 300%, or at least 400% of the second perimeter.

For some applications, the main stent-graft is sized and configured to positioned such that (a) a distal, radially larger, descending-aorta axial portion of the stent-graft, including the distal main-module end thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion of the main stent-graft, including the proximal main-module end thereof, is disposed in the left subclavian artery, and (c) an arch axial portion, axially between the descending-aorta axial portion and the supra-arch axial portion, is disposed in the aortic arch.

For some applications, when the main stent-graft is unconstrained in its radially-expanded state, the main stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the main structural stent elements, (b) has a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, and/or (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end.

For some applications, the dissection-reinforcement axial portion has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft. This greater strength increases the force that the dissection-reinforcement axial portion applies to a tear of the aortic dissection, thereby sealing the tear. (It is noted that providing the entire length of the main stent-graft with a high strength has at least two drawbacks: stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.) For some applications, the dissection-reinforcement axial portion is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, the main structural stent elements of the dissection-reinforcement axial portion are arranged as a plurality of circumferential stent springs of the dissection-reinforcement axial portion. For some applications, a height, measured axially along the main stent-graft, of at least one of the stent springs of the dissection-reinforcement axial portion varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, the portion of structural stent elements included by the dissection-reinforcement axial portion is a first portion of the structural stent elements, and when the stent-graft is unconstrained in the radially-expanded state: (a) the main stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, (b) the distal-end axial portion axially extends along the stent-graft from the distal main-module end for a distance equal to between 5% and 32% of a greatest perimeter of the main stent-graft distally to a distal end of the lateral fenestration, and (c) the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft.

For some applications, the dissection-reinforcement axial portion includes a first plurality of the stent springs, and the main stent-graft includes a distal axial portion, which includes a second plurality of the stent springs. The distal axial portion is disposed along the main stent-graft distal and axially adjacent to the distal dissection-reinforcement end, and extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end. Typically, the distal axial portion extends to and reaches the distal main-module end. The stent springs have respective average heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft). An average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs. For these applications, the dissection-reinforcement axial portion is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.

The secondary stent-graft typically comprises a secondary generally tubular support element and a secondary covering element that is attached to and at least partially covers the secondary support element. The support element typically comprises a plurality of secondary structural stent elements. When the secondary module (and the secondary stent-graft) is unconstrained in the radially-expanded state thereof:

- the secondary module is shaped so as to define a proximal secondary-module end, a sealing interface distal to the proximal secondary-module end, and a central longitudinal axis therebetween. The sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module;
- the secondary module is shaped so as to define a distal secondary-module end; and
- the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.

For some applications, at least one of the secondary structural stent elements traverses the lateral opening when the secondary module is unconstrained in the radially-expanded state thereof. Such traversal may provide additional structural strength to the secondary module at the lateral opening.

In some applications of the present invention, another configuration of secondary module is provided. In this configuration, when the secondary module is unconstrained in the radially-expanded state thereof:

- the at least one lateral opening includes at least first and second lateral openings;
- the secondary covering element is shaped so as to define the first and second lateral openings, each of which begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module;
- the first and second lateral openings face in different first and second radial directions extending from the central longitudinal axis; and
- the first and the second lateral openings at least partially axially overlap along the central longitudinal axis.

In some applications of the present invention, further alternative configurations of secondary module are provided. In these configurations, when the secondary module is unconstrained in the radially-expanded state thereof, (a) the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (b) a greatest axial length of the secondary-module lateral fenestration equals at least 33% of the first perimeter of the distal main-module end of the main stent-graft of the main module, when the main module is unconstrained in the radially-expanded state thereof. For some applications, a greatest width of the secondary-module lateral fenestration, measured circumferentially around the secondary module, equals at least 16% of the first perimeter of the distal main-module end of the main stent-graft of the main module.

For some applications, the secondary module further comprises a flexible sheet, which (a) is blood-sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from the secondary border (toward or past the central longitudinal axis) when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet, which facilitates the radially-inward extension of the flexible sheet from secondary border.

There is therefore provided, in accordance with an application of the present invention, apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:

a generally tubular support element, which includes a plurality of structural stent elements; and

a covering element that is attached to and at least partially covers the support element,

wherein when the stent-graft is unconstrained in a radially-expanded state:

- the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
- a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end, and
- the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection-reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft.

For some applications:

the portion of the structural stent elements included by the dissection-reinforcement axial portion is a first portion of the structural stent elements, and

when the stent-graft is unconstrained in the radially-expanded state:

- the stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, and
- the distal-end axial portion axially extends along the stent-graft from the distal end of stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and
- the distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire stent-graft.

For some applications, an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state. Alternatively, for some applications, the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.

For some applications, a distance between the distal dissection-reinforcement end and the distal stent-graft end equals between 32% and 160% of a largest perimeter of the stent-graft when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 22% of a greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the first perimeter equals at least 250% of the second perimeter.

For any of the applications described above, the dissection-reinforcement axial portion may be configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and a height, measured axially along the stent-graft, of at least one of the stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, the structural stent elements of the dissection-reinforcement axial portion may be arranged as a plurality of circumferential stent springs, and for each one of the stent springs, a height, measured axially along the stent-graft, of the stent spring may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, the first perimeter may be between 5 and 15 cm, and the second perimeter may be between 2.5 and 5.7 cm.

For any of the applications described above, the stent-graft may be shaped so as to define exactly one lateral fenestration when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction, and when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.

There is further provided, in accordance with an application of the present invention, apparatus including a generally tubular stent-graft, which has distal and proximal stent-graft ends and includes:

a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs; and

a covering element that is attached to and at least partially cover the support element,

wherein when the stent-graft is unconstrained in a radially-expanded state:

- the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,
- a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end,
- the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a first plurality of the stent springs, (b) has (i) a distal dissection-reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (d) is configured to be generally straight,
- the stent-graft includes a distal axial portion, which (a) includes a second plurality of the stent springs, (b) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (c) extends along the stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end,
- the stent springs have respective average heights, measured axially along the stent-graft, and
- an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.

For some applications, each of the average heights of the first plurality of the stent springs is less than 75% of the average heights of the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a second one of the second plurality of stent springs, other than the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the average of the average heights of the first plurality of the stent springs is less than 75% of each of the average heights of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the distal axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.

For some applications, an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.

For some applications, an axial spacing between two of the first plurality of the stent springs equals less than 10% of an average of the average heights of the two stent springs.

For some applications, the first perimeter equals at least 300% of the second perimeter.

For some applications, the dissection-reinforcement axial portion extends along the stent-graft for a distance equal to between 10% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.

For some applications, the distal axial portion extends to and reaches the distal stent-graft end.

For any of the applications described above, the average height of at least one of the first plurality of stent springs may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, for each one of the first plurality of stent springs, the average height thereof may vary by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.

For any of the applications described above, optionally:

if the distal axial portion, when the stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the distal axial portion, the distal axial portion experiences kinking only when at least an axial portion of the first curved tube has less than a first radius of curvature, and

if the dissection-reinforcement axial portion, when the stent-graft is in the radially-expanded state, is placed and constrained in a second curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the dissection-reinforcement axial portion, the dissection-reinforcement axial portion experiences kinking only when at least an axial portion of the second curved tube has less than a second radius of curvature, which second radius of curvature is at least 30% less than the first radius of curvature.

There is still further provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:

a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and

a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element,

wherein when the secondary module is unconstrained in a radially-expanded state thereof:

- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module, and
- the secondary covering element is shaped so as to define at least one lateral opening that begins at and extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for a distance equal to at least 50% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis.

For some applications, a greatest width of the at least one lateral opening, measured circumferentially around the secondary module, equals at least 90 degrees circumferentially around the proximal secondary-module end, the 90 degrees being measured at the sealing interface.

For some applications, at least one of the secondary structural stent elements traverses the at least one lateral opening when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the at least one lateral opening extends from the proximal secondary-module end toward the sealing interface along at least 70% of a greatest width of the secondary module, measured perpendicular to the central longitudinal axis when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the cross-sectional area of the secondary module, measured perpendicular to the central longitudinal axis, gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, when the secondary module is unconstrained in the radially-expanded state thereof:

the at least one lateral opening may include at least first and second lateral openings,

the secondary covering element may be shaped so as to define the first and the second lateral openings, each of extends from the proximal secondary-module end toward the sealing interface along the central longitudinal axis for the distance equal to at least 50% of the greatest width of the secondary module,

the first and the second lateral openings may face in different first and second radial directions extending from the central longitudinal axis, and

the first and the second lateral openings may at least partially axially overlap along the central longitudinal axis.

For some applications, the first and the second lateral openings axially coincide along the central longitudinal axis. For some applications, the first and the second radial directions are opposite each other. For some applications, the secondary covering element is shaped so as to define two portions, which (a) extend to and reach the proximal secondary-module end, and (b) are shaped so as to define respective concave inner surfaces that face each other and the central longitudinal axis, and (c) are not joined to each other at the proximal secondary-module end.

For any of the applications described above, the at least one lateral opening may include exactly one lateral opening. For some applications, when the secondary module is unconstrained in the radially-expanded state thereof, the lateral opening faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.

For any of the applications described above, a first perimeter of the distal main-module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially-expanded state thereof.

For any of the applications described above:

the lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,

when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element may be shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,

the stent-graft system may further include a generally tubular tertiary stent-graft, and

the main and the tertiary stent-grafts may be configured such that the tertiary stent-graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.

There is additionally provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:

a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and

wherein when the secondary module is unconstrained in a radially-expanded state thereof:

- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
- the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and
- a greatest axial length of the secondary-module lateral fenestration, measured parallel to the central longitudinal axis, equals at least 33% of a first perimeter of the distal main-module end when the main module is unconstrained in the radially-expanded state thereof.

For some applications, at least one of the secondary structural stent elements traverses the secondary-module lateral fenestration.

For some applications, the greatest axial length of the secondary-module lateral fenestration equals at least 50% of the first perimeter of the distal main-module end when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the cross-sectional area of the secondary module gradually tapers from the proximal secondary-module end to the sealing interface when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, the at least one secondary-module lateral fenestration may include exactly one secondary-module lateral fenestration. For some applications, when the secondary module is unconstrained in the radially-expanded state thereof, the secondary-module lateral fenestration faces in a first radial direction extending from the central longitudinal axis, and a portion of the secondary covering element that faces in a second radial direction opposite the first radial direction extends to and reaches the proximal secondary-module end.

For any of the applications described above, the first perimeter of the distal main-module end may equal at least 200%, e.g., at least 300%, of a second perimeter of the proximal main-module end when the main module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, the secondary module may further include a flexible sheet, which (a) is blood-sealingly joined to a portion of the secondary border, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet.

For any of the applications described above:

the main-module lateral fenestration may be an inferior first lateral fenestration, which faces in a first radial direction,

the stent-graft system may further include a generally tubular tertiary stent-graft, and

There is yet additionally provided, in accordance with an application of the present invention; apparatus including a stent-graft system, which includes:

a main module, which has distal and proximal main-module ends, and includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element, wherein the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration when the main module is unconstrained in a radially-expanded state thereof; and

a secondary module, which includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet,

wherein when the secondary module is unconstrained in a radially-expanded state thereof:

- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, wherein the sealing interface is sized and configured to form a blood-impervious seal with the main-module lateral fenestration of the main module,
- the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and
- the flexible sheet (a) is blood-sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border when the secondary module is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, a portion of the secondary structural stent elements are attached to the flexible sheet.

For some applications:

the main-module lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,

when the main stent-graft is unconstrained in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction,

the stent-graft system further includes a generally tubular tertiary stent-graft, and

the main and the tertiary stent-grafts are configured such that the tertiary stent-graft forms a blood-impervious seal with the main stent-graft around the superior second lateral fenestration when the tertiary stent-graft is disposed therethrough, and the main stent-graft is in the radially-expanded state thereof and the tertiary stent-graft is in a radially-expanded state thereof.

There is also provided, in accordance with an application of the present invention, apparatus including a stent-graft system, which includes:

wherein when the secondary module is unconstrained in a radially-expanded state thereof:

- the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring-portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end,
- the sealing interface is sized and configured to form a blood-impervious seal with the lateral fenestration of the main module,
- the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and
- the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.

For some applications, the anchoring axial portion has the greatest anchoring-portion width at an axial location at an axial distance from the proximal secondary-module end equal to between 33% and 60% of the anchoring-portion length, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the greatest anchoring-portion width is at least 50% greater than the greatest sealing-interface width at the narrowest portion of the distal sealing interface, when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the axial covering distance from the distal sealing interface is equal to between 20% and 100% of an axial distance between the distal sealing interface and an axial location of the greatest anchoring-portion width, the axial distance measured along the central longitudinal axis, when the secondary module is unconstrained in the radially-expanded state thereof. For some applications, the axial covering distance from the distal sealing interface is equal to between 30% and 60% of the axial distance between the distal sealing interface and the axial location of the greatest anchoring-portion width, when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the axial covering distance equals between 10% and 35% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, the axial covering distance is at least 15% of the anchoring-portion length, when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, the anchoring axial portion may include a plurality of the secondary structural stent elements, each of which has two longitudinal portions that extend toward the distal sealing interface, and an intermediary longitudinal portion that curves around the proximal secondary-module end, when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, the anchoring axial portion may include a plurality of the secondary structural stent elements, some of which touch one another, and none of which are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, an uncovered axial portion of the anchoring portion may extend from the proximal secondary-module end to a proximal end of the covered axial portion, for an axial uncovered distance equal to between 30 and 120 mm, when the secondary module is unconstrained in the radially-expanded state thereof.

For any of the applications described above, the greatest proximal-end width may equal zero.

There is further provided, in accordance with an application of the present invention, a method for treating a patient including:

endovascularly introducing a generally tubular stent-graft, while in a radially-compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements, and (b) a covering element that is attached to and at least partially covers the support element; and

For some applications:

the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,

when the main stent-graft is in the radially-expanded state, the main covering element and the main support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction, and

positioning the stent-graft includes positioning the stent-graft such that (a) the proximal stent-graft end is positioned in the left common carotid artery, (b) the inferior first lateral fenestration is disposed in the aortic arch, with the inferior first lateral fenestration facing upstream generally toward the ascending aorta, and (c) the superior second lateral fenestration is axially aligned with and faces the left subclavian artery.

There is still further provided, in accordance with an application of the present invention, a method for treating a patient including:

endovascularly introducing a generally tubular stent-graft, while in a radially-compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality circumferential stent springs, and (b) a covering element that is attached to and at least partially covers the support element; and

thereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of a distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a first plurality of the stent springs, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, and (iv) is configured to be generally straight when the stent-graft is unconstrained in the radially-constrained state, (d) the stent-graft includes a distal axial portion, which (i) includes a second plurality of the stent springs, (ii) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (iii) extends along the stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end, (e) the stent springs have respective average heights, measured axially along the stent-graft, and (f) an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.

For some applications:

the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,

There is additionally provided, in accordance with an application of the present invention, a method for treating a patient including:

endovascularly introducing a main module, while in a radially-compressed state thereof, and positioning the main module such that (a) a proximal main-module end of the main module is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery left subclavian artery, and a left common carotid artery, and (b) a distal main-module end of the main module is positioned in a descending aorta, wherein the main module includes a generally tubular main stent-graft, which includes (a) a main generally tubular support element, which includes main structural stent elements, and (b) a main covering element that is attached to and at least partially covers the support element;

thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta;

endovascularly introducing and passing a secondary module, while in a radially-compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and

For some applications:

the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction,

There is yet additionally provided, in accordance with an application of the present invention, a method for treating a patient including:

thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta;

endovascularly introducing and passing a secondary module, while in a radially-compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and at least partially covers the secondary support element; and

There is also provided, in accordance with an application of the present invention, a method for treating a patient including:

thereafter, transitioning the main stent-graft to a radially-expanded state thereof, in which the main covering element and the main support element are shaped so as to together define a main-module lateral fenestration that is disposed in the aortic arch, with the main-module lateral fenestration facing upstream generally toward an ascending aorta;

endovascularly introducing and passing a secondary module, while in a radially-compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the main-module lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, (b) a secondary covering element that is attached to and at least partially covers the secondary support element, and (c) a flexible sheet; and

thereafter, transitioning the secondary module to a radially-expanded state thereof, in which (a) the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) a central longitudinal axis therebetween, such that the sealing interface forms a blood-impervious seal with the main-module lateral fenestration of the main module, (b) the secondary covering element is shaped so as to define at least one secondary-module lateral fenestration disposed distal to the proximal secondary-module end and proximal to the sealing interface, and (c) the flexible sheet (i) is blood-sealingly joined to a portion of a secondary border of the secondary-module lateral fenestration, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end of the secondary border, and (ii) extends radially inward from the secondary border when the secondary module is unconstrained in the radially-expanded state thereof.

There is further provided, in accordance with an application of the present invention, a method for treating a patient including:

endovascularly introducing and passing a secondary module, while in a radially-compressed state thereof, through a distal portion of the main stent-graft such that the secondary module is disposed through the lateral fenestration and is disposed partially in the aortic arch, wherein the secondary module includes a non-bifurcated secondary stent-graft, which includes (a) a secondary support element, which includes secondary structural stent elements, and (b) a secondary covering element that is attached to and partially covers the secondary support element; and

thereafter, transitioning the secondary module to a radially-expanded state thereof, in which the secondary module is shaped so as to define (a) a proximal secondary-module end, (b) a sealing interface distal to the proximal secondary-module end, and (c) an anchoring axial portion therebetween having a central longitudinal axis and an anchoring-portion length, measured along the central longitudinal axis from the distal sealing interface to the proximal secondary-module end, such that the sealing interface forms a blood-impervious seal with the lateral fenestration of the main module, the secondary covering element at least covers the secondary support element along a covered axial portion of the anchoring axial portion, which covered axial portion extends proximally from the distal sealing interface for an axial covering distance equal to between 10% and 50% of the anchoring-portion length, the axial covering distance measured along the central longitudinal axis, wherein the secondary support element is uncovered proximally to the secondary covering element, and the anchoring axial portion has a greatest anchoring-portion width that is (a) greater than a greatest proximal-end width at the proximal secondary-module end and (b) at least 20% greater than a greatest sealing-interface width at a narrowest portion of the distal sealing interface, the greatest anchoring-portion, sealing-interface, and proximal-end widths measured perpendicular to the central longitudinal axis.

The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic illustration of multi-component stent-graft system, in accordance with an application of the present invention;

FIGS. 2A-B are schematic illustrations of a main module of the multi-component stent-graft system of FIG. 1, in accordance with respective applications of the present invention;

FIG. 3 is a schematic illustration of a secondary module of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention;

FIG. 4 is a schematic illustration of another configuration of the secondary module of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention;

FIGS. 5 and 6 are schematic illustrations of alternative configurations of the secondary module of the multi-component stent-graft system of FIG. 1, in accordance with respective applications of the present invention;

FIG. 7 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention;

FIG. 8 is a schematic illustration of yet another configuration of the secondary module of the secondary module of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention;

FIG. 9 is a schematic illustration of still another configuration of the secondary module of the secondary module of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention;

FIG. 10 is a schematic illustration of the secondary module of FIG. 9 deployed in an aortic arch, sealingly coupled to a lateral fenestration of a main module of the multi-component stent-graft system, in accordance with an application of the present invention;

FIG. 11 is a schematic illustration of another multi-component stent-graft system, in accordance with an application of the present invention;

FIG. 12 is a schematic illustration of a main module of the multi-component stent-graft system of FIG. 11, in accordance with an application of the present invention;

FIGS. 13A and 13B are schematic illustrations of respective configurations of a tertiary module of the multi-component stent-graft system of FIG. 11, in accordance with respective applications of the present invention;

FIGS. 14A-B are schematic illustrations of kinking properties of different axial portions of a main stent-graft of the multi-component stent-graft system of FIG. 1, in accordance with an application of the present invention; and

FIG. 15 is a schematic illustration of kinking in a stent-graft.

DETAILED DESCRIPTION OF APPLICATIONS

FIG. 1 is a schematic illustration of multi-component stent-graft system 10, in accordance with an application of the present invention. In some applications of the present invention, multi-component stent-graft system 10 is provided for treating a Type B aortic dissection 12. The system is configured to be deployed in a thoracic aorta 14 and a left subclavian artery 16, and, optionally, a left common carotid artery 18. The multi-component stent-graft system is configured to be deployed in a straightforward procedure. The stent-grafts of the system are assembled in situ to accommodate the dimensions of the particular patient's anatomy, generally without requiring prior customization of the stent-grafts or in situ modifications to the stent-grafts, which might be expensive and/or complex.

Typically, upon deployment, the multi-component stent-graft system defines a blood-flow path from an ascending aorta 17, over an aortic arch 19, and to the descending aorta. The multi-component stent-graft system additionally provides or allows blood-flow paths to the three branches of the aortic arch.

Multi-component stent-graft system 10 comprises a main module 20 and, for some applications, a secondary module 22. Main module 20 comprises a generally tubular main stent-graft 24, and secondary module 22 comprises a non-bifurcated secondary stent-graft 26. The stent-grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s). FIG. 1 shows the stent-grafts in their radially-expanded states in situ. For some applications, the stent-grafts are relaxed in their radially-expanded states. For some applications, the stent-grafts are configured to be self-expanding. For example, they may be heat-set to assume their radially-expanded states.

Exemplary Configuration of the Main Module

Reference is still made to FIG. 1, and is additionally made to FIGS. 2A-B, which are schematic illustrations of main module 20 that comprises main stent-graft 24, in accordance with respective applications of the present invention. FIGS. 2A-B show main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Main stent-graft 24 typically comprises a main generally tubular support element 30 and a main covering element 32 that is attached to and at least partially covers (e.g., only partially covers) the main support element. Support element 30 typically comprises a plurality of main structural stent elements 31. For some applications, main structural stent elements 31 are arranged as a plurality of circumferential stent springs 33. For some applications, support element 30, as well as support elements 130, 230 and 330, which are described hereinbelow, comprise a super-elastic alloy, such as Nitinol. Main covering element 32 serves as a blood flow guide through at least a portion of the main stent-graft. Main covering element 32 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.

Main covering element 32 and main support element 30 are shaped so as to together define a lateral fenestration 34, e.g., exactly one lateral fenestration 34, through main stent-graft 24, which lateral fenestration has distal and proximal fenestration ends 35 and 37, when main stent-graft 24 is unconstrained in its radially-expanded state. As used in the present application, including in the claims, a “fenestration” is an opening entirely surrounded by a covering element. For example, lateral opening 174, described hereinbelow with reference to FIG. 3, is not a fenestration, because the lateral opening extends from the end of module and thus is not surrounded by the covering element along a proximal edge of the lateral opening. When multi-component stent-graft system 10 is implanted as shown in FIG. 1, lateral fenestration 34 serves as an inferior lateral fenestration. Typically, at least a portion of the border of lateral fenestration 34 is defined by an undulating portion of one or more of structural stent elements 31.

For some applications, when main stent-graft 24 is unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise, a first perimeter P1 of a distal main-module end 36 of main stent-graft 24 (and main module 20) is greater than a second perimeter P2 of a proximal main-module end 38 of the main stent-graft (and the main module), and/or a first cross-sectional area of the distal main-module end 36 is greater than a second cross-sectional area of proximal main-module end 38. For applications in which main stent-graft 24 is generally cylindrical when unconstrained in its radially-expanded state, first and second perimeters P1 and P2 are first and second diameters. For example, first perimeter P1 may equal at least 150% of second perimeter P2, such as at least 200%, at least 250%, at least 300%, or at least 400%, and/or the first cross-sectional area may equal at least 225% of the second cross-sectional area, such as at least 400%, at least 625%, at least 900%, or at least 1600%.

For example, first perimeter P1 may be at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 (e.g., 9) and 13 cm, and second perimeter P2 may be at least 2.5 cm, no more than 5.7 cm, and/or between 2.5 and 5.7 cm, such as at least 3 cm, no more than 4.5 cm, and/or between 3 and 4.5 cm.

For some applications, when main stent-graft 24 is unconstrained in its radially-expanded state, a perimeter of lateral fenestration 34 is at least 5 cm, no more than 15 cm, and/or between 5 and 15 cm, such as at least 7.5 cm, e.g., at least 9 cm, no more than 13 cm, and/or between 7.5 cm (e.g., 9 cm) and 13 cm. For some applications, when main stent-graft 24 is unconstrained in its radially-expanded state, a perimeter of lateral fenestration 34 is at least 80%, no more than 120%, and/or between 80% and 120% of first perimeter P1, and/or at least 150%, no more than 250%, and/or between 150% and 250% of second perimeter P2.

For some applications, secondary module 22 is not necessary for providing blood flow into the lateral fenestration, and is thus optionally not provided. For example, secondary module 22 may not be necessary when lateral fenestration 34 is sufficiently large (e.g., has a perimeter of at least 9 cm and/or at least 80% of first perimeter P1).

For some applications, main stent-graft 24, when unconstrained in its radially-expanded state, has an axial length of at least 5 cm, no more than 40 cm, and/or between 5 and 30 cm, such as at least 10 cm, no more than 30 cm, and/or between 10 and 30 cm. (The axial length is measured along a central longitudinal axis 40 of the stent-graft.) For some applications, main stent-graft 24, when unconstrained in its radially-expanded state, has a greatest perimeter (at any axial location along the stent-graft) of at least 7.5 cm, no more than 19 cm, and/or between 7.5 and 19 cm, such as at least 12.5 cm, no more than 16 cm, and/or between 12.5 and 16 cm. These values are typical for adult subjects, in which the vast majority of dissections occur. For pediatric subjects, in which dissections are rare, these dimensions may be reduced by a factor of up to 1:3.

For some applications, such dimensions allow main stent-graft 24 to be positioned such that (a) a distal, radially larger, descending-aorta axial portion 42 of the stent-graft, including distal main-module end 36 thereof, is disposed in the aorta downstream from the bifurcation with the left subclavian artery, at least partially in the upper part of the descending aorta, (b) a proximal, radially smaller, supra-arch axial portion 44 of the main stent-graft, including proximal main-module end 38 thereof, is disposed in left subclavian artery 16, as shown in FIG. 1, and (c) an arch axial portion 46, axially between descending-aorta axial portion 42 and supra-arch axial portion 44, is disposed in aortic arch 19. Typically, arch axial portion 46 at least partially axially overlaps fenestration 34, since the fenestration should be disposed in the apex of the arch. For some applications, descending-aorta axial portion 42 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) an average perimeter of the portion of the aorta in which it is disposed. For some applications, supra-arch axial portion 44 has an average perimeter that is greater than (e.g., between 5% and 15% greater than) the average perimeter of the portion of the left subclavian artery in which it is disposed.

For some applications, when main stent-graft 24 is unconstrained in its radially-expanded state, the main stent-graft includes a dissection-reinforcement axial portion 48, which:

- includes a portion of main structural stent elements 31;
- has a distal dissection-reinforcement end 50;
- has a proximal dissection-reinforcement end 52 that is disposed along the stent-graft no more than 20 mm proximal to proximal fenestration end 37; proximal dissection-reinforcement end 52 may be either proximal or distal to proximal fenestration end 37. For some applications, proximal dissection-reinforcement end 52 is disposed along the main stent-graft no more proximal than distal fenestration end 35 when the stent-graft is unconstrained in the radially-expanded state, such as shown in FIGS. 1 and 2A. For other applications, proximal dissection-reinforcement end 52 is disposed along the main stent-graft between distal fenestration end 35 and proximal fenestration end 37, inclusive, when the stent-graft is unconstrained in the radially-expanded state, such as shown in FIG. 2B; and/or
- extends along the stent-graft for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of a greatest perimeter of the stent-graft distally to distal fenestration end 35, such as at least 10%, no more than 20%, and/or between 10% and 20%.

For some applications, dissection-reinforcement axial portion 48 has a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft, such as at least 15% greater, or at least 30% greater. This greater strength increases the force that dissection-reinforcement axial portion 48 applies to a tear 56 of aortic dissection 12, thereby sealing the tear. Tear 56 is generally located in an upper portion of thoracic aorta 14, and sometimes additionally in a lower portion of left subclavian artery 16 and/or at the take-off of left subclavian artery 16 from thoracic aorta 14. (It is noted that providing the entire length of the main stent-graft with a high strength has at least two drawbacks: stent-grafts with higher strengths are more difficult to deploy, and are more likely to cause damage to the vasculature.)

Typically, an arch axial portion 46 and dissection-reinforcement axial portion 48 do not include any bare main structural stent elements 31, such that main covering element 32 intervenes between the stent elements and the blood vessel wall in the vicinity of tear 56.

For some applications, an axial length of dissection-reinforcement axial portion 48 is at least 1 cm, no more than 3 cm, and/or between 1 and 3 cm when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, a distance D1 between distal dissection-reinforcement end 50 and distal main-module end 36 is at least 32%, no more than 160%, and/or between 32% and 160% of a largest perimeter of the main stent-graft, when the main stent-graft is unconstrained in the radially-expanded state. Alternatively or additionally, for some applications, distance D1 is at least 3 cm, no more than 5 cm, and/or between 3 and 5 cm, when the main stent-graft is unconstrained in the radially-expanded state. Still further alternatively or additionally, for some applications, when the main stent-graft is unconstrained in the radially-expanded state: (a) distance D1 equals between at least 20%, no more than 66%, and/or between 20% and 66% of a total length L1 of main stent-graft 24, and/or (b) a distance D2 between proximal dissection-reinforcement end 52 and proximal main-module end 38 equals at least 33%, no more than 80%, and/or between 33% and 80% of total length L1.

For some applications, such as shown in FIGS. 2A-B, dissection-reinforcement axial portion 48 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, main structural stent elements 31 of dissection-reinforcement axial portion 48 are arranged as a plurality of circumferential stent springs 33 of dissection-reinforcement axial portion 48. For some applications, a strut height H, measured axially along the main stent-graft, of at least one of stent springs 33 of dissection-reinforcement axial portion 48 varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state. For some applications, for each one of stent springs 33 of dissection-reinforcement axial portion 48, height H of the stent spring varies by less than 10% around a circumference of the stent spring when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, the portion of structural stent elements 31 included by dissection-reinforcement axial portion 48 is a first portion of structural stent elements 31, and when the stent-graft is unconstrained in the radially-expanded state: (a) main stent-graft 24 includes a distal-end axial portion 54, which includes a second portion of structural stent elements 31, (b) distal-end axial portion 54 axially extends along the stent-graft from distal main-module end 36 for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of a greatest perimeter of the main stent-graft distally to distal fenestration end 35, such as at least 11%, no more than 22%, and/or between 11% and 22%, and (c) distal-end axial portion 54 has a radial strength that is at least a 10% greater than the average radial strength of the entire main stent-graft.

For some applications, dissection-reinforcement axial portion 48 includes a first plurality 60 of stent springs 33, and main stent-graft 24 includes a distal axial portion 58, which includes a second plurality 62 of stent springs 33. Distal axial portion 58 is disposed along the main stent-graft distal and axially adjacent to distal dissection-reinforcement end 50, and extends along the main stent-graft for a distance equal to at least 5%, no more than 32%, and/or between 5% and 32% of the greatest perimeter of the main stent-graft distally to the distal fenestration end 35. Typically, distal axial portion 58 extends to and reaches the distal main-module end 36. Stent springs 33 have respective average strut heights, measured axially along the main stent-graft (the height of each stent spring is averaged circumferentially around the stent-graft). An average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a proximal-most one 64 of second plurality 62 of stent springs 33. These smaller average heights generally allow dissection-reinforcement axial portion 48 to bend without the stent springs thereof coming into contact with one another. For these applications, dissection-reinforcement axial portion 48 is typically configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, each of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state. For some applications, the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of the average height of a second one 66 of second plurality 62 of stent springs 33, other than proximal-most one 64 of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state. For some applications, the average of the average heights of first plurality 60 of stent springs 33 is less than 75% (e.g., less than 70%) of each of the average heights of second plurality 62 of stent springs 33 when the main stent-graft is unconstrained in the radially-expanded state.

For some applications, an axial spacing S between two of first plurality 60 of stent springs 33 of dissection-reinforcement axial portion 48 equals less than 10% of an average of the average heights H of the two stent springs 33. Such low axial spacing between the stent springs of reduces the risk of kinking of dissection-reinforcement axial portion 48. The use of a greater axial spacing S would make dissection-reinforcement axial portion 48 more prone to kinking, such as described hereinbelow with reference to FIG. 14.

For some applications, distal axial portion 58 is configured to be generally straight when the main stent-graft is unconstrained in the radially-expanded state.

Exemplary Configuration of the Secondary Module

Reference is still made to FIG. 1, and is additionally made to FIG. 3, which is a schematic illustration of secondary module 22 that comprises secondary stent-graft 26, in accordance with an application of the present invention. FIG. 3 shows secondary stent-graft 26 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Secondary stent-graft 26 typically comprises a secondary generally tubular support element 130 and a secondary covering element 132 that is attached to and at least partially covers (e.g., only partially covers) the secondary support element. Support element 130 typically comprises a plurality of secondary structural stent elements 131. For some applications, secondary structural stent elements 131 are arranged as a plurality of circumferential stent springs 133. Secondary covering element 132 serves as a blood flow guide through at least a portion of the secondary stent-graft. Secondary covering element 132 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.

When secondary module 22 (and secondary stent-graft 26) is unconstrained in the radially-expanded state thereof:

- secondary module 22 is shaped so as to define a proximal secondary-module end 138, a sealing interface 172 distal to proximal secondary-module end 138, and a central longitudinal axis 140 therebetween. Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20;
- secondary module 22 is shaped so as to define a distal secondary-module end 136; and
- secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for a distance D3 equal to at least 50% (e.g., at least 70%) of a greatest width W1 of secondary module 22, measured perpendicular to central longitudinal axis 140. In other words, lateral opening 174 reaches proximal secondary-module end 138, is thus not entirely surrounded by secondary covering element 132, and therefore is not a fenestration, as defined hereinabove with reference to FIGS. 1 and 2A-B.

For some applications, a greatest width W2 of at least one lateral opening 174, measured circumferentially around secondary module 22, equals at least 90 degrees circumferentially around proximal secondary-module end 138, the 90 degrees being measured at sealing interface 172 (even though the lateral opening typically does not extend to the sealing interface, and may have its greatest width W2 at proximal secondary-module end 138).

For some applications, at least one of secondary structural stent elements 131 traverses lateral opening 174 when the secondary module is unconstrained in the radially-expanded state thereof. By way of example, in FIG. 3 two secondary structural stent elements 131B are shown traversing lateral opening 174. Alternatively, a single secondary structural stent element 131B, or three or more secondary structural stent elements 131B, traverse lateral opening 174. Such traversal may provide additional structural strength to secondary module 22 at the lateral opening. For some applications of this configuration, support element 130 is shaped so as to define a complete tube, which is only partially covered by secondary covering element 132. For some other applications in which none of secondary structural stent elements 131 traverses lateral opening 174, support element 130 is shaped so as to define a partial tube circumferentially.

For some applications, a cross-sectional area of secondary module 22, measured perpendicular to central longitudinal axis 40, gradually tapers from proximal secondary-module end 138 to sealing interface 172 when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, such as shown in FIG. 3, the at least one lateral opening 174 comprises exactly one lateral opening 174. For some of these applications, when secondary module 22 is unconstrained in the radially-expanded state thereof, lateral opening 174 faces in a first radial direction extending from central longitudinal axis 140, and a portion 176 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary-module end 138. In other words, secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite lateral opening 174, such that lateral opening 174 and portion 176 face in radially-opposite directions.

Typically, upon deployment of main and secondary modules 20 and 22, the stent-grafts together provide continuous coverage covering element material along the blood flow path, which may help prevent further trauma to aorta, and sub-tears in the aorta.

Exemplary Deployment of the Multi-Component Stent-Graft System

Reference is again made to FIG. 1, which schematically shows a portion of a typical aorta, including thoracic aorta 14, which includes an upper part of ascending aorta 17, and aortic arch 19, and an upper part of a supra-renal descending aorta. Also shown are the three branches of aortic arch 19: a brachiocephalic artery 70, left common carotid artery 18, and left subclavian artery 16.

In an exemplary transluminal delivery procedure for implanting multi-component stent-graft system 10, as configured in FIGS. 1 and 2A-B, the stent-grafts of system 10 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states.

Typically, the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left subclavian artery 16. Main stent-graft 24 of main module 20 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until main stent-graft 24 is partially disposed in left subclavian artery 16 and partially disposed in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place. The main stent-graft is held in place as the outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube. Main stent-graft 24 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in FIG. 1. Alternatively, the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.

Descending-aorta axial portion 42 of main stent-graft 24, including distal main-module end 36, is positioned in the upper part of the descending aorta, and supra-arch axial portion 44 of main stent-graft 24, including proximal main-module end 38, is positioned in left subclavian artery 16. Arch axial portion 46 of main stent-graft 24, including lateral fenestration 34, is disposed in aortic arch 19, with the lateral fenestration facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left subclavian artery 16. For some applications, proper rotational alignment and/or axial orientation of the lateral fenestration is achieved using fluoroscopy. For example, main stent-graft 24 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the lateral fenestration.

A guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 24, out of lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17. Secondary stent-graft 26 of secondary module 22 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 24 in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place.

The secondary stent-graft is rotationally aligned such that the at least one lateral opening 174 faces left common carotid artery 18, so as to allow blood flow to the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70). The secondary stent-graft may comprise one or more radiopaque markers to facilitate such proper rotational alignment. For example, the radiopaque markers may be positioned on one or more edges of the at least one lateral opening. Secondary module 22 is positioned so as to not block brachiocephalic artery 70 or left common carotid artery 18.

The secondary stent-graft is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube. Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels. Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 24 and lateral fenestration 34, while the main stent-graft is in its radially-expanded state.

A distal portion of secondary stent-graft 26, including distal secondary-module end 136, is positioned within main stent-graft 24, and sealing interface 172 of secondary stent-graft 26 is sealingly coupled to lateral fenestration 34 of main stent-graft 24. A proximal portion of secondary stent-graft 26, including proximal secondary-module end 138, is positioned in aortic arch 19. As mentioned, the at least one lateral opening 174 faces left common carotid artery 18. Secondary module 22 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into lateral fenestration 34 of main stent-graft 24.

For some applications, main and secondary stent-grafts 24 and 26, when in their respective radially-expanded states, constrained by the respective blood vessels in which they are positioned, have some or all of the dimensional and/or strength characteristics described herein as applicable when the stent-grafts are unconstrained in their radially-expanded states. By way of example and not limitation, (a) first perimeter P1 of distal main-module end 36 of main stent-graft 24 may equal at least 200% (e.g., at least 250%, at least 300%, or at least 400%) of second perimeter P2 of proximal main-module end 38 of the main stent-graft, (b) proximal dissection-reinforcement end 52 may be disposed along the main stent-graft no more than 20 mm proximal to proximal fenestration end 37, (c) dissection-reinforcement axial portion 48 may extends along the main stent-graft for a distance equal to between 5% and 32% of the greatest perimeter of the main stent-graft distally to distal fenestration end 35, and/or dissection-reinforcement axial portion 48 may have a radial strength that is at least 10% greater than an average radial strength of the entire main stent-graft.

Alternative Configurations of the Secondary Module

Reference is now made to FIG. 4, which is a schematic illustration of another configuration of secondary module 22, in accordance with an application of the present invention. In this configuration, when secondary module 22 is unconstrained in the radially-expanded state thereof:

- the at least one lateral opening 174 includes at least first and second lateral openings 174A and 174B;
- secondary covering element 132 is shaped so as to define first and second lateral openings 174A and 174B, each of which begins at and extends from proximal secondary-module end 138 toward sealing interface 172 along central longitudinal axis 140 for distance D3 equal to at least 50% of greatest width W1 of secondary module 22;
- first and second lateral openings 174A and 174B face in different first and second radial directions extending from central longitudinal axis 140; and
- first and second lateral openings 174A and 174B at least partially axially overlap along central longitudinal axis 140.

For some applications, such as shown in FIG. 4, first and second lateral openings 174A and 174B axially coincide along central longitudinal axis 140. For some applications, such as shown in FIG. 4, the first and the second radial directions are opposite each other; in other words first and second lateral openings 174A and 174B face in radially-opposite directions.

For some applications, such as shown in FIG. 4, secondary covering element 132 is shaped so as to define two portions 176A and 176B, which (a) extend to and reach proximal secondary-module end 138, and (b) are shaped so as to define respective concave inner surfaces 178A and 178B that face each other and central longitudinal axis 140, and (c) are not joined to each other at proximal secondary-module end 138.

During deployment of secondary module 22 in aortic arch 19, such as described hereinabove with reference to FIG. 1, the secondary module is rotationally aligned such that one of first and second lateral openings 174A and 174B faces left common carotid artery 18, so as to allow blood flow into the left common carotid artery (and, for applications in which the secondary stent-graft is long enough, so as to allow blood flow into brachiocephalic artery 70). The other of the lateral openings faces downward toward the wall of aortic arch 19 opposite the left common carotid artery, and may serve to prevent blood from becoming trapped below the bottom side of the secondary module, which might cause blood coagulation.

Reference is now made to FIGS. 5 and 6, which are schematic illustrations of alternative configurations of secondary module 22, in accordance with respective applications of the present invention. In these configurations, when secondary module 22 is unconstrained in the radially-expanded state thereof:

- secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and central longitudinal axis 140 therebetween. Sealing interface 172 is sized and configured to form a blood-impervious seal with lateral fenestration 34 of main module 20;
- secondary module 22 is shaped so as to define distal secondary-module end 136;
- secondary covering element 132 is shaped so as to define at least one secondary-module lateral fenestration 134 disposed distal to proximal secondary-module end 138 and proximal to sealing interface 172, and
- a greatest axial length L2 of secondary-module lateral fenestration 134, measured parallel to central longitudinal axis 140, equals at least 33% (e.g., at least 50%) of first perimeter P1 of distal main-module end 36 of main stent-graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof.

For some applications, a greatest width W3 of secondary-module lateral fenestration 134, measured circumferentially around secondary module 22, equals at least 16% of first perimeter P1, such as at least 25% of first perimeter P1. These dimensions of greatest axial length L2 and greatest width W3 may allow secondary-module lateral fenestration 134 to allow sufficient blood flow to both left common carotid artery 18 and brachiocephalic artery 70.

Because secondary-module lateral fenestration 134 does not reach proximal secondary-module end 138, secondary covering element 132 is shaped so as to define an additional fixation zone 184 between secondary-module lateral fenestration 134 and proximal secondary-module end 138.

For some applications, at least one of secondary structural stent elements 131 traverses secondary-module lateral fenestration 134 when secondary module 22 is unconstrained in the radially-expanded state thereof. By way of example, in FIG. 5 one secondary structural stent element 131B is shown traversing secondary-module lateral fenestration 134, and in FIG. 6 two secondary structural stent elements 131B are shown traversing secondary-module lateral fenestration 134. Alternatively, three or more secondary structural stent elements 131B traverse secondary-module lateral fenestration 134. Such traversal may provide additional structural strength to secondary module 22 at the secondary-module lateral fenestration.

Typically, at least a portion of the border of secondary-module lateral fenestration 134 is defined by an undulating portion of one or more of secondary structural stent elements 131.

For some applications, a cross-sectional area of secondary module 22 gradually tapers from proximal secondary-module end 138 to sealing interface 172 when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, such as shown in FIG. 5, the at least one secondary-module lateral fenestration 134 comprises exactly one secondary-module lateral fenestration 134. For some of these applications, when secondary module 22 is unconstrained in the radially-expanded state thereof, secondary-module lateral fenestration 134 faces in a first radial direction extending from central longitudinal axis 140, and a portion 182 of secondary covering element 132 that faces in a second radial direction opposite the first radial direction extends to and reaches proximal secondary-module end 138. In other words, secondary module 22 is covered by secondary covering element 132 on the side circumferentially opposite secondary-module lateral fenestration 134, such that secondary-module lateral fenestration 134 and portion 182 face in radially-opposite directions.

During deployment of secondary module 20 in aortic arch 19, such as described hereinabove with reference to FIG. 1, the secondary module is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18, so as to allow blood flow into the left common carotid artery.

Reference is made to FIG. 6. For some applications, secondary module 22 further comprises a flexible sheet 190, which (a) is blood-sealingly joined to a portion of a secondary border 180 of secondary-module lateral fenestration 134, which portion extends around at least 25% of a perimeter of the secondary border and includes a distal end 192 of secondary border 180 when secondary module 22 is unconstrained in the radially-expanded state thereof, and (b) extends radially inward from secondary border 180 (toward or past central longitudinal axis 140) when secondary module 22 is unconstrained in the radially-expanded state thereof. For some applications, a portion 194 of secondary structural stent elements 131 are attached to flexible sheet 190, which facilitates the radially-inward extension of flexible sheet 190 from secondary border 180.

As mentioned above, during deployment of secondary module 20 in aortic arch 19, such as described hereinabove with reference to FIG. 1, the secondary module is rotationally aligned such that secondary-module lateral fenestration 134 faces left common carotid artery 18. Flexible sheet 190 serves to direct a portion of the blood flow into the left common carotid artery.

Reference is now made to FIG. 7, which is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention. In this configuration, secondary module 22 is shaped so as to define proximal secondary-module end 138, sealing interface 172, and an anchoring axial portion 160 therebetween having central longitudinal axis 140 and an anchoring-portion length L3, measured along the central longitudinal axis from distal sealing interface 172 to proximal secondary-module end 138. Anchoring axial portion 160 is typically configured to (a) accommodate the anatomy of aortic arch 19 without blocking blood flow in the arch or to left common carotid artery 18 or brachiocephalic artery 70, (b) provide support for anchoring the secondary module in the aortic arch, and/or (c) provide support for secondary covering element 132, as described below.

Anchoring axial portion 160 includes a plurality (e.g., at least 8) of secondary structural stent elements 131, which, for example may comprise respective wires. For some applications, each of plurality of secondary structural stent elements 131 has two longitudinal portions 168 that extend toward (e.g., reach) distal sealing interface 172, and an intermediary longitudinal portion 170 that curves around proximal secondary-module end 136, when secondary module 22 is unconstrained in the radially-expanded state thereof (by way of example, one of such secondary structural stent elements 131 is labeled with reference numeral 167 in FIG. 7). Curved portions 170 of the plurality of secondary structural stent elements 131 may or may not converge at a single point at proximal secondary-module end 136. For some applications, the plurality of secondary structural stent elements 131 of anchoring axial portion 160 includes some structural stent elements that touch one another (e.g. at or near proximal secondary-module end 138), and no structural stent elements that are fixed to one another, when the secondary module is unconstrained in the radially-expanded state thereof.

For some applications, secondary structural stent elements 131 may include a loop element, e.g. a polygonal or elliptical (e.g., circular) loop, at proximal secondary-module end 136, to which loop element respective ends of the plurality of secondary structural stent elements 131 are coupled (configuration not shown).

In this configuration, when secondary module 22 is unconstrained in the radially-expanded state thereof, secondary covering element 132 at least covers secondary support element 130 along a covered axial portion 162 of anchoring axial portion 160. Secondary structural stent elements 131 of anchoring axial portion 160 provide support for secondary covering element 132, holding the secondary covering element open so as to facilitate blood flow to sealing interface 172 and through lateral fenestration 34 of main stent-graft 24.

Covered axial portion 162 extends proximally from distal sealing interface 172 for an axial covering distance D4 equal to at least 10% (e.g., at least 15%, such as at least 20%), no more than 50% (e.g., no more than 35%), and/or between 10% and 50% (e.g., between 10% and 35%, or between 20% and 35%) of anchoring-portion length L3, axial covering distance D4 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof. Secondary support element 130 is uncovered proximally to secondary covering element 132. When secondary module 22 is unconstrained in the radially-expanded state thereof, an uncovered axial portion 163 of anchoring axial portion 160 extends from proximal secondary-module end 138 to a proximal end 165 of covered axial portion 162, for an axial uncovered distance D7 equal to at least 50% (e.g., at least 65%), no more than 90% (e.g., no more than 80%), and/or between 50% and 90% (e.g., between 65% and 80%) of anchoring-portion length L3, measured along central longitudinal axis 140.

Typically, when secondary module 22 is unconstrained in the radially-expanded state thereof, anchoring axial portion 160 has a greatest anchoring-portion width W4 that is (a) greater than a greatest proximal-end width W5 at the proximal secondary-module end (W5 is optionally zero, as shown, for configurations in which the plurality of secondary structural stent elements 131 converge at a single point) and (b) at least 20%, e.g., at least 50%, at least 75%, or at least 100%, greater than a greatest sealing-interface width W6 at a narrowest portion 164 of distal sealing interface 172, greatest anchoring-portion, sealing-interface, and proximal-end widths W4, W5, and W6 measured perpendicular to central longitudinal axis 140. For some applications, anchoring axial portion 160 has greatest anchoring-portion width W4 at an axial location 166 at an axial distance D5 from proximal secondary-module end 138 equal to at least 33%, no more than 60%, and/or between 33% and 60% of anchoring-portion length L3, axial distance D5 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.

For some applications, axial covering distance D4 from distal sealing interface 172 is equal to at least 20% (e.g., at least 30%), no more than 100% (e.g., no more than 60%), and/or between 20% and 100% (e.g., between 30% and 60%) of an axial distance D6 between distal sealing interface 172 and axial location 166 of greatest anchoring-portion width W4, axial distance D6 measured along central longitudinal axis 140, when secondary module 22 is unconstrained in the radially-expanded state thereof.

For some applications, when secondary module 22 is unconstrained in the radially-expanded state thereof:

- anchoring-portion length L3 equals at least 50 mm, no more than 150 mm, and/or between 50 and 150 mm;
- greatest width W4 equals at least 30 mm, no more than 60 mm, and/or between 30 and 60 mm;
- greatest proximal-end width W5 equals at least 0 mm, no more than 35 mm, and/or between 0 and 35 mm, and/or at least 0 mm, no more than 40% of W4, and/or between 0 mm and 40% of W4;
- greatest sealing-interface width W6 equals at least 25 mm, no more than 40 mm, and/or between 25 and 40 mm;
- axial covering distance D4 equals at least 10 mm, no more than 30 mm, and/or between 10 and 30 mm;
- axial distance D5 equals at least 20 mm, no more than 80 mm, and/or between 20 and 80 mm;
- axial distance D6 equals at least 30 mm, no more than 80 mm, and/or between 30 and 80 mm; and/or
- axial uncovered distance D7 equals at least 30 mm, no more than 120 mm, and/or between 30 and 120 mm.

Reference is now made to FIG. 8, which is a schematic illustration of yet another configuration of secondary module 22, in accordance with an application of the present invention. FIG. 8 shows secondary module 22 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20. In this configuration, secondary covering element 132 is shaped so as to define at least one lateral opening 174 that begins at and extends from proximal secondary-module end 138 toward sealing interface 172, such as described hereinabove with reference to FIGS. 3 and 4. Alternatively, the configuration of FIG. 8 may be implemented in combination with the configurations described hereinabove with reference to FIGS. 5, 6, and/or 7.

In this configuration, secondary module 22 comprises an extension structure 200, which is disposed radially outward of a fluid-flow path defined by secondary module 22, in a same radially direction as one of the at least one lateral opening of secondary covering element 132 (in the case of the configuration shown in FIGS. 3 and 4, at least one lateral opening 174, and in the case of FIGS. 5 and 6, at least one secondary-module lateral fenestration 134). Extension structure 200 typically comprises one or more of secondary structural stent elements 131. Extension structure 200 is shaped so as to help hold secondary module 22 properly positioned in aortic arch 19.

For some applications, at least one of secondary structural stent elements 131 traverses the lateral opening when the secondary module is unconstrained in the radially-expanded state thereof, and extension structure 200 is coupled to the lateral opening.

Reference is now made to FIGS. 9 and 10, which are schematic illustrations of a secondary module 222, in accordance with an application of the present invention. FIG. 9 shows secondary module 222, and FIG. 10 shows secondary module 222 deployed in aortic arch 19, sealingly coupled to lateral fenestration 34 of main module 20. FIG. 9 shows secondary module 222 unconstrained in its radially-expanded state, i.e., no forces are applied to the module by a delivery tool, walls of a blood vessel, or otherwise.

Secondary module 222 comprises a non-bifurcated secondary stent-graft 226, which typically comprises a secondary generally tubular support element 230 and a secondary covering element 232 that is attached to and at least partially covers a covered axial portion 242 of support element 230 and at least partially does not cover an uncovered axial portion 244 of support element 230. For some applications, secondary covering element 232 partially covers an overlap axial portion 246 along which first and second axial portions 244 and 246 axially overlap; for example, a distal end 250 of secondary covering element 232 may be generally diagonally-shaped, such as shown in FIG. 9.

Support element 230 typically comprises a plurality of secondary structural stent elements 231. For some applications, secondary structural stent elements 231 are arranged as a plurality of circumferential stent springs 233. Secondary covering element 232 serves as a blood flow guide through at least a portion of the secondary stent-graft. Secondary covering element 232 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.

As shown in FIG. 10, secondary module 222 is configured to be partially inserted into main module 20, such that uncovered axial portion 244 is positioned within main module 20, and covered axial portion 242 is partially positioned outside of and partially positioned within main module 20, through lateral fenestration 34. A portion of secondary covering element 232 passes through lateral fenestration 34, so as to form a blood-tight seal with main module 20. The portion of covered axial portion 242 positioned outside of main module 20 is short enough so as to not block blood flow left common carotid artery 18 or brachiocephalic artery 70.

Reference is now made to FIGS. 11, 12, and 13A-B. FIG. 11 is a schematic illustration of a multi-component stent-graft system 310, in accordance with an application of the present invention. Multi-component stent-graft system 310 comprises a main module 320, a secondary module 322, and typically a tertiary module 328, which comprise respective stent-grafts, as described below. The stent-grafts are configured to assume radially-compressed states, such as when initially positioned in one or more outer tubes of one or more delivery tools, and to assume radially-expanded states upon being deployed from the outer tube(s). FIG. 11 shows the stent-grafts in their radially-expanded states in situ.

FIG. 12 is a schematic illustration of main module 320, in accordance with an application of the present invention. FIG. 12 shows main stent-graft 24 unconstrained in its radially-expanded state, i.e., no forces are applied to the stent-graft by a delivery tool, walls of a blood vessel, or otherwise. Other than as described hereinbelow, main module 320 may implement any or all of the features of main module 20, described hereinabove with reference to FIGS. 1 and 2A-B, including, but not limited to, dissection-reinforcement axial portion 48, descending-aorta axial portion 42, supra-arch axial portion 44, arch axial portion 46, and/or distal axial portion 58. Main module 320 comprises a generally tubular main stent-graft 324, such as described hereinabove with reference to FIGS. 2A-B regarding main stent-graft 24.

Unlike stent-graft 24, main covering element 32 and main support element 30 of main stent-graft 324 are shaped so as to together define two lateral fenestrations through main stent-graft 324: a first lateral fenestration 34, as defined by stent-graft 24, and a second lateral fenestration 368, when main stent-graft 324 is unconstrained in its radially-expanded state. Typically, when main stent-graft 324 is unconstrained in its radially-expanded state, first lateral fenestration 34 faces in a first radial direction, and second lateral fenestration 368 faces in a second radially direction generally circumferentially opposite the first radial direction. For example, if the stent-graft is viewed from one end, the first lateral fenestration may be disposed at between 11 o'clock and 1 o'clock (e.g., at 12 o'clock), and the second lateral fenestration may disposed at between 5 o'clock and 7 o'clock (e.g., at 6 o'clock).

When multi-component stent-graft system 310 is implanted as shown in FIG. 11, first lateral fenestration 34 serves as an inferior lateral fenestration, and second lateral fenestration 368 serves as a superior lateral fenestration.

Typically, a first perimeter of first (inferior) lateral fenestration 34 equals at least 200%, no more than 400%, and/or between 200% and 400% of a second perimeter of second (superior) lateral fenestration 368.

For some applications, supra-arch axial portion 44 of main stent-graft 324 is internally lined with ePTFE film, or main covering element 32 of main stent-graft 324 comprises entirely ePTFE (and thus does not comprise any polyester). Optionally, main covering element 32 along other portions of the main stent-graft comprises polyester. (This configuration may also be implemented in main stent-graft 24, described hereinabove with reference to FIGS. 1 and 2A-B.)

Other than as described hereinbelow, secondary module 322 may implement any of the configurations of secondary module 20 described hereinabove with reference to FIGS. 1, 3, 4, 5, 6, 7, 8, 9, and/or 10 mutatis mutandis. By way of example and not limitation, secondary module is shown in FIG. 11 in the configuration of secondary module 20 shown in FIGS. 1 and 3. (For applications in which secondary module is configured as described hereinabove with reference to FIG. 5 and/or FIG. 6, greatest axial length L2 of secondary-module lateral fenestration 134 may be less than described hereinabove, e.g., may equal at least 20% of first perimeter P1 of distal main-module end 36 of main stent-graft 24 of main module 20, when the main module is unconstrained in the radially-expanded state thereof. In the configuration described with reference to FIGS. 11 and 12, secondary-module lateral fenestration 134 need only be sufficiently large to allow sufficient blood flow to brachiocephalic artery 70.)

FIGS. 13A and 13B are schematic illustrations of respective configurations of tertiary module 328, in accordance with respective applications of the present invention. Tertiary module 328 comprises a generally tubular tertiary stent-graft 380, which typically comprises a tertiary generally tubular support element 382 and a tertiary covering element 384 that is attached to and at least partially covers (e.g., only partially covers) the tertiary support element. Tertiary module 328 and stent-graft 380 have distal and proximal ends 381 and 383. Support element 382 typically comprises a plurality of tertiary structural stent elements 386. For some applications, tertiary structural stent elements 386 are arranged as a plurality of circumferential stent springs 388. Tertiary covering element 384 serves as a blood flow guide through at least a portion of the tertiary stent-graft. Tertiary covering element 384 typically comprises at least one biologically-compatible substantially blood-impervious flexible sheet, which is attached (such as by stitching) to at least a portion of the respective support element, on either side of the surfaces defined by the support element. The flexible sheet may comprise, for example, a polymeric material (e.g., a polyester, or polytetrafluoroethylene), a textile material (e.g., polyethylene terephthalate (PET)), natural tissue (e.g., saphenous vein or collagen), or a combination thereof.

In the configuration shown in FIG. 13A, tertiary module 328 is shaped so as to define a sealing interface 372, which is similar to sealing interface 172 described hereinabove with reference to FIGS. 3, 4, 5, 6, and 7, and/or hereinbelow with reference to FIGS. 1, 3, 4, 5, 6, 7, 8, and 11. Sealing interface 372 is sized and configured to form a blood-impervious seal with second (superior) lateral fenestration 368 of main module 320, as shown in FIG. 11. For some applications, sealing interface 372 and/or second (superior) lateral fenestration 368 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev.

In the configuration shown in FIG. 13A, tertiary module 328 includes covered and uncovered axial portions, similar to the covered and uncovered axial portions 242 and 244 described hereinabove with reference to FIG. 9. Tertiary module 328 may implement any of the features described hereinabove with reference to FIG. 9, mutatis mutandis. Tertiary module 328 is sized and configured to form a blood-impervious seat with second (superior) lateral fenestration 368 of main module 320, using the techniques described hereinabove with reference to FIG. 10, mutatis mutandis.

Reference is again made to FIG. 11. In an exemplary transluminal delivery procedure for implanting multi-component stent-graft system 310, the stent-grafts of system 310 are endovascularly (typically percutaneously) introduced into the thoracic aorta, such as via one of the iliac arteries, while the stent-grafts are positioned in one or more outer tubes of a delivery tool in their radially-compressed states.

Typically, the exemplary procedure begins with the advancing of a guidewire up the descending aorta and into left common carotid artery 18. Main stent-graft 324 of main module 320 is initially positioned in its radially-compressed state within an outer tube of a delivery tool, typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until main stent-graft 324 is partially disposed in left common carotid artery 18 and partially disposed in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place. The main stent-graft is held in place as the outer tube is withdrawn, thereby delivering the main stent-graft from the outer tube. Main stent-graft 324 typically self-expands, until it assumes its radially-expanded state, upon reaching typically about 80-90% of its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels, as shown in FIG. 11. Alternatively, the main stent-graft (and/or the other stent-grafts, as described hereinbelow) is delivered using an over-the-wire (OTW) approach, in which the guidewire is left in place until the stent-graft is expanded, and thereafter the guidewire is withdrawn.

Descending-aorta axial portion 42 of main stent-graft 324, including distal main-module end 336, is positioned in the upper part of the descending aorta, and supra-arch axial portion 44 of main stent-graft 324, including proximal main-module end 338, is positioned in left common carotid artery 18. First (inferior) lateral fenestration 34 is disposed in aortic arch 19 facing upstream, generally toward ascending aorta 17, in a vicinity of the bifurcation of aortic arch 19 and left common carotid artery 18. Second (superior) lateral fenestration 368 is axially aligned with and faces left subclavian artery 16. For some applications, proper rotational alignment and/or axial orientation of the first and/or second lateral fenestrations is achieved using fluoroscopy. For example, main stent-graft 324 may comprise one or more radiopaque markers in a vicinity of (e.g., on a periphery of) the one or both of the lateral fenestrations.

A guidewire (either the same guidewire used to deploy the main stent-graft, or a second guidewire) is advanced up the descending aorta, through a proximal portion of main stent-graft 324, through second (superior) lateral fenestration 368, and into left subclavian artery 16. Tertiary stent-graft 380 of tertiary module 328 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft, or a second outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until tertiary stent-graft 380 is partially disposed in left subclavian artery 16, and partially disposed within radially-expanded main stent-graft 324. The guidewire is withdrawn, leaving the outer tube in place.

The tertiary stent-graft is held in place as the outer tube is withdrawn, thereby delivering the tertiary stent-graft from the outer tube. Tertiary stent-graft 380 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the left subclavian artery. Tertiary stent-graft 380 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and second (superior) lateral fenestration 368, while the main stent-graft is in its radially-expanded state.

A proximal portion of tertiary stent-graft 380, including distal end 383, is positioned within main stent-graft 324, and tertiary covering element 384 (e.g., at sealing interface 372 in the configuration shown in FIGS. 11 and 13A) of tertiary stent-graft 380 is sealingly coupled to second (superior) lateral fenestration 368 of main stent-graft 324.

A guidewire (either the same guidewire used to deploy the main stent-graft and/or tertiary stent-graft, or another guidewire) is advanced up the descending aorta, through a distal portion of main stent-graft 324, out of first (inferior) lateral fenestration 34, and into aortic arch 19, extending toward, or partially into, ascending aorta 17. Secondary stent-graft 26 of secondary module 322 is positioned in its radially-compressed state within an outer tube of a delivery tool (either the same outer tube used to deploy the main stent-graft and/or the tertiary stent-graft, or another outer tube), typically near a leading end of the outer tube. The outer tube is advanced over the guidewire, until secondary stent-graft 26 is partially disposed in aortic arch 19, extending toward, or partially into, ascending aorta 17, and partially disposed within radially-expanded main stent-graft 324 in the upper part of the descending aorta. The guidewire is withdrawn, leaving the outer tube in place.

The secondary stent-graft is held in place as the outer tube is withdrawn, thereby delivering the secondary stent-graft from the outer tube. Secondary stent-graft 26 typically self-expands, until it assumes its radially-expanded state, upon reaching its maximum unconstrained size, and/or being constrained from further expansion by the wall of the blood vessels. Secondary stent-graft 26 is thus adapted for transluminal delivery in its radially-compressed state through a portion of main stent-graft 324 and first (inferior) lateral fenestration 34, while the main stent-graft is in its radially-expanded state.

A distal portion of secondary stent-graft 26, including distal secondary-module end 136, is positioned within main stent-graft 324, and sealing interface 172 of secondary stent-graft 26 is sealingly coupled to first (inferior) lateral fenestration 34 of main stent-graft 324. A proximal portion of secondary stent-graft 26, including proximal secondary-module end 138, is positioned in aortic arch 19. As mentioned, the at least one lateral opening 174 faces left common carotid artery 18. Secondary module 322 reduces blood turbulence in the aortic arch, and serves as a funnel that creates a gradual taper of the blood flow into first (inferior) lateral fenestration 34 of main stent-graft 324.

Alternatively, secondary module 322 is deployed before tertiary module 328 is deployed.

Reference is made to FIGS. 1, 3, 4, 5, 6, 7, 8, and 11. For some applications, sealing interface 172 is shaped so as to define a neck portion longitudinally flanked by proximal and distal portions. The neck portion is generally radially narrower than the proximal and distal portions. For some applications, sealing interface 172 and/or lateral fenestration 34 implement sealing techniques described in US Patent Application Publication 2012/0179236 to Benary et al. and/or PCT Publication WO 2013/005207 to Shalev, which are incorporated herein by reference. Alternatively, all of the configurations of secondary module 22 described with reference to FIGS. 1, 3, 4, 5, 6, 7, 8, and 11 may implement the sealing techniques described hereinabove regarding secondary module 222 with reference to FIGS. 9 and 10 (i.e., rather than defining a narrower neck portion, secondary covering element 132 of secondary stent-graft 26 may instead only partially axially cover secondary support element 130 and define sealing interface 172B).

Reference is again made to FIGS. 1 and 2A-B, as well as to FIGS. 14A-B, which are schematic illustrations of kinking properties of different axial portions of main stent-graft 24, in accordance with an application of the present invention. For some applications:

- if distal axial portion 58 of main stent-graft 24, when the main stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube 390 having a circular cross-section and an inner diameter equal to an outer diameter of distal axial portion 58, distal axial portion 58 experiences kinking only when at least an axial portion 392 of the first curved tube has less than a first radius of curvature r1, as shown in FIG. 14A, and
- if dissection-reinforcement axial portion 48 of main stent-graft 24, when the main stent-graft is in the radially-expanded state, is placed and constrained in a second curved tube 394 having a circular cross-section and an inner diameter equal to an outer diameter of dissection-reinforcement axial portion 48, dissection-reinforcement axial portion 48 experiences kinking only when at least an axial portion 396 of the second curved tube has less than a second radius of curvature r2, which second radius of curvature is at least 30%, e.g., at least 50%, less than the first radius of curvature r1, as shown in FIG. 14B.

As used in the present application, including in the claims, “kinking,” means that the graft material of main covering element 32 is pinched, or folded in a blood-flow-disturbing manner. It is noted that the outer diameters of the axial portions may vary axially therealong, in which case the inner diameters of the curved tubes would also correspondingly vary. It is also noted that the first and second curved tubes are not elements of multi-component stent-graft system 10, but are rather geometric constructs used to describe certain features of the main stent-graft.

Reference is now made to FIG. 15, which is a schematic illustration of kinking in a stent-graft 400. As described hereinabove with reference to FIGS. 2A-B and 14A-B, for some applications dissection-reinforcement axial portion 48 is configured to avoid kinking. Without such configuration, for example if substantial axial spacing is provided between adjacent stent springs 402 of stent-graft 400, the stent-graft would be more prone to kinking 404, as shown in FIG. 14.

Although multi-component stent-graft systems 10 and 310 are generally described herein as being used for treating Type B aortic dissection, the scope of the present invention also includes using these systems for treating other conditions, such as aortic aneurysms.

The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:

- U.S. application Ser. No. 12/529,936, filed Sep. 4, 2009, which issued as U.S. Pat. No. 8,317,856
- U.S. Provisional Application 60/892,885, filed Mar. 5, 2007
- U.S. Provisional Application 60/991,726, filed Dec. 2, 2007
- U.S. Provisional Application 61/219,758, filed Jun. 23, 2009
- U.S. Provisional Application 61/221,074, filed Jun. 28, 2009
- U.S. application Ser. No. 13/380,278, filed Dec. 22, 2011, which published as US Patent Application Publication 2012/0150274
- U.S. application Ser. No. 13/384,075, filed Jan. 13, 2012, which published as US Patent Application Publication 2012/0179236
- U.S. application Ser. No. 13/505,996, filed May 3, 2012, which published as US Patent Application Publication 2012/0310324
- U.S. application Ser. No. 13/512,778, filed Sep. 24, 2012, which published as US Patent Application Publication 2013/0013050
- U.S. application Ser. No. 13/513,397, filed Jun. 1, 2012, which published as US Patent Application Publication 2012/0330399
- U.S. application Ser. No. 13/514,240, filed Jun. 6, 2012, which published as US Patent Application Publication 2013/0013051
- U.S. application Ser. No. 13/577,161, filed Aug. 3, 2012, which published as US Patent Application Publication 2013/0035751
- U.S. application Ser. No. 13/031,871, filed Feb. 22, 2011, which published as US Patent Application Publication 2011/0208289
- U.S. Provisional Application 61/496,613, filed Jun. 14, 2011
- U.S. Provisional Application 61/505,132, filed Jul. 7, 2011
- U.S. Provisional Application 61/529,931, filed Sep. 1, 2011
- PCT Application PCT/IL2012/000060, filed Feb. 2, 2012, which published as PCT Publication WO 2012/104842
- PCT Application PCT/IL2012/000083, filed Feb. 16, 2012, which published as PCT Publication WO 2012/111006
- PCT Application PCT/IL2012/000095, filed Mar. 1, 2012, which published as PCT Publication WO 2012/117395
- PCT Application PCT/IL2012/000148, filed Apr. 4, 2012, which published as PCT Publication WO 2013/030818
- PCT Application PCT/IL2012/000190, filed May 15, 2012, which published as PCT Publication WO 2013/171730
- U.S. patent application Ser. No. 13/523,296, filed Jun. 14, 2012, which published as US Patent Application Publication 2012/0323305
- PCT Application PCT/IL2012/000241, filed Jun. 19, 2012, which published as PCT Publication WO 2012/176187
- PCT Application PCT/IL2012/000269, filed Jul. 2, 2012, which published as PCT Publication WO 2013/005207
- PCT Application PCT/IL2012/050424, filed Oct. 29, 2012, which published as PCT Publication WO 2013/065040
- PCT Application PCT/IL2012/050506, filed Dec. 4, 2012, which published as PCT Publication WO 2013/084235
- U.S. Provisional Application 61/749,965, filed Jan. 8, 2013, entitled, “Minimization of stent-graft migration during implantation”

It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims

1. Apparatus comprising a generally tubular stent-graft, which has distal and proximal stent-graft ends and comprises: a generally tubular support element, which comprises a plurality of structural stent elements; anda covering element that is attached to and at least partially covers the support element,wherein when the stent-graft is unconstrained in a radially-expanded state: the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end, andthe stent-graft includes a dissection-reinforcement axial portion, which (a) includes a portion of the structural stent elements, (b) has (i) a distal dissection-reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance, and (d) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft, wherein the distance is equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end.
2. The apparatus according to claim 1, wherein the portion of the structural stent elements included by the dissection-reinforcement axial portion is a first portion of the structural stent elements, andwherein when the stent-graft is unconstrained in the radially-expanded state: the stent-graft includes a distal-end axial portion, which includes a second portion of the structural stent elements, andthe distal-end axial portion axially extends along the stent-graft from the distal end of the stent-graft for a distance, wherein the distance is equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, andthe distal-end axial portion has a radial strength that is at least a 10% greater than the average radial strength of the entire stent-graft.
3. The apparatus according to claim 1, wherein an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.
4. The apparatus according to claim 1, wherein the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
5. The apparatus according to claim 1, wherein the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
6. The apparatus according to claim 1, wherein a distance between the distal dissection-reinforcement end and the distal stent-graft end equals between 32% and 160% of a largest perimeter of the stent-graft when the stent-graft is unconstrained in the radially-expanded state.
7. The apparatus according to claim 1, wherein the dissection-reinforcement axial portion extends along the stent-graft for a distance when the stent-graft is unconstrained in the radially-expanded state, wherein the distance is equal to between 10% and 22% of a greatest perimeter of the stent-graft distally to the distal fenestration end.
8. The apparatus according to claim 1, wherein the first perimeter equals at least 250% of the second perimeter.
9. The apparatus according to claim 1, wherein the dissection-reinforcement axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
10. The apparatus according to claim 1, wherein the structural stent elements of the dissection-reinforcement axial portion are arranged as a plurality of circumferential stent springs, and wherein a height, measured axially along the stent-graft, of at least one of the stent springs varies by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
11. The apparatus according to claim 1, wherein the stent-graft is shaped so as to define exactly one lateral fenestration when the stent-graft is unconstrained in the radially-expanded state.
12. The apparatus according to claim 1, wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction, andwherein, when the stent-graft is unconstrained in the radially-expanded state, the covering element and the support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
13. Apparatus comprising a generally tubular stent-graft, which has distal and proximal stent-graft ends and comprises: a generally tubular support element, which comprises a plurality of structural stent elements arranged as a plurality of circumferential stent springs; anda covering element that is attached to and at least partially covers the support element,wherein when the stent-graft is unconstrained in a radially-expanded state: the covering element and the support element are shaped so as to together define a lateral fenestration having distal and proximal fenestration ends,a first perimeter of the distal stent-graft end equals at least 200% of a second perimeter of the proximal stent-graft end,the stent-graft includes a dissection-reinforcement axial portion, which (a) includes a first plurality of the stent springs, (b) has (i) a distal dissection-reinforcement end and (ii) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (c) extends along the stent-graft for a distance, and (d) is configured to be generally straight, wherein the distance is equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end,the stent-graft includes a distal axial portion, which (a) includes a second plurality of the stent springs, (b) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (c) extends along the stent-graft for a distance, wherein the distance is equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end,the stent springs have respective average heights, measured axially along the stent-graft, andan average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.
14. The apparatus according to claim 13, wherein each of the average heights of the first plurality of the stent springs is less than 75% of the average heights of the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
15. The apparatus according to claim 13, wherein the average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a second one of the second plurality of stent springs, other than the proximal-most one of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
16. The apparatus according to claim 13, wherein the average of the average heights of the first plurality of the stent springs is less than 75% of each of the average heights of the second plurality of stent springs when the stent-graft is unconstrained in the radially-expanded state.
17. The apparatus according to claim 13, wherein the distal axial portion is configured to be generally straight when the stent-graft is unconstrained in the radially-expanded state.
18. The apparatus according to claim 13, wherein an axial length of the dissection-reinforcement axial portion is between 1 and 3 cm when the stent-graft is unconstrained in the radially-expanded state.
19. The apparatus according to claim 13, wherein the proximal dissection-reinforcement end is disposed along the stent-graft no more proximal than the distal fenestration end when the stent-graft is unconstrained in the radially-expanded state.
20. The apparatus according to claim 13, wherein the proximal dissection-reinforcement end is disposed along the stent-graft between the distal fenestration end and the proximal fenestration end, inclusive, when the stent-graft is unconstrained in the radially-expanded state.
21. The apparatus according to claim 13, wherein an axial spacing between two of the first plurality of the stent springs equals less than 10% of an average of the average heights of the two stent springs.
22. The apparatus according to claim 13, wherein the first perimeter equals at least 300% of the second perimeter.
23. The apparatus according to claim 13, wherein the dissection-reinforcement axial portion extends along the stent-graft for a distance when the stent-graft is unconstrained in the radially-expanded state, wherein the distance is equal to between 10% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end.
24. The apparatus according to claim 13, wherein the distal axial portion extends to and reaches the distal stent-graft end.
25. The apparatus according to claim 13, wherein the average height of at least one of the first plurality of stent springs varies by less than 10% around a circumference of the stent spring when the stent-graft is unconstrained in the radially-expanded state.
26. The apparatus according to claim 13, wherein, if the distal axial portion, when the stent-graft is in the radially-expanded state, is placed and constrained in a first curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the distal axial portion, the distal axial portion experiences kinking only when at least an axial portion of the first curved tube has less than a first radius of curvature, andwherein, if the dissection-reinforcement axial portion, when the stent-graft is in the radially-expanded state, is placed and constrained in a second curved tube having a circular cross-section and an inner diameter equal to an outer diameter of the dissection-reinforcement axial portion, the dissection-reinforcement axial portion experiences kinking only when at least an axial portion of the second curved tube has less than a second radius of curvature, which second radius of curvature is at least 30% less than the first radius of curvature.
27. The apparatus according to claim 13, wherein the lateral fenestration is an inferior first lateral fenestration, which faces in a first radial direction, andwherein, when the stent-graft is unconstrained in the radially-expanded state, the covering element and the support element are shaped so as to together define a superior second lateral fenestration, which faces in a second radial direction generally opposite the first radial direction.
28. A method for treating a patient comprising: endovascularly introducing a generally tubular stent-graft, while in a radially-compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements, and (b) a covering element that is attached to and at least partially covers the support element; andthereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of the distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, and (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a portion of the structural stent elements, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for an axial distance, and (iv) has a radial strength that is at least 10% greater than an average radial strength of the entire stent-graft, wherein the axial distance is equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end.
29. A method for treating a patient comprising: endovascularly introducing a generally tubular stent-graft, while in a radially-compressed state, and positioning the stent-graft such that (a) a proximal stent-graft end of the stent-graft is positioned in a branch of an aortic arch selected from the group consisting of: a left subclavian artery, and a left common carotid artery, and (b) a distal stent-graft end of the stent-graft is positioned in a descending aorta, wherein the stent-graft includes (a) a generally tubular support element, which includes a plurality of structural stent elements arranged as a plurality of circumferential stent springs, and (b) a covering element that is attached to and at least partially covers the support element; andthereafter, transitioning the stent-graft to a radially-expanded state, in which (a) the covering element and the support element are shaped so as to together define a lateral fenestration that is disposed in the aortic arch, with the lateral fenestration facing upstream generally toward an ascending aorta, the lateral fenestration having distal and proximal fenestration ends, (b) a first perimeter of the distal stent-graft end of the stent-graft equals at least 200% of a second perimeter of the proximal stent-graft end, (c) the stent-graft includes a dissection-reinforcement axial portion, which (i) includes a first plurality of the stent springs, (ii) has (x) a distal dissection-reinforcement end and (y) a proximal dissection-reinforcement end that is disposed along the stent-graft no more than 20 mm proximal to the proximal fenestration end, (iii) extends along the stent-graft for a distance, and (iv) is configured to be generally straight when the stent-graft is unconstrained in the radially-constrained state, wherein the distance is equal to between 5% and 32% of a greatest perimeter of the stent-graft distally to the distal fenestration end, (d) the stent-graft includes a distal axial portion, which (i) includes a second plurality of the stent springs, (ii) is disposed along the stent-graft distal and axially adjacent to the distal dissection-reinforcement end, (iii) extends along the stent-graft for a distance, wherein the distance is equal to between 5% and 32% of the greatest perimeter of the stent-graft distally to the distal fenestration end, (e) the stent springs have respective average heights, measured axially along the stent-graft, and (f) an average of the average heights of the first plurality of the stent springs is less than 75% of the average height of a proximal-most one of the second plurality of the stent springs.

CROSS-REFERENCE TO RELATED APPLICATION

The present application is the U.S. national stage of International Application PCT/IL2014/050174, filed Feb. 18, 2014, which claims priority from U.S. Provisional Application 61/775,964, filed Mar. 11, 2013, which is assigned to the assignee of the present application and is incorporated herein by reference.

PCT Information

Filing Document	Filing Date	Country	Kind
PCT/IL2014/050174	2/18/2014	WO	00

Publishing Document	Publishing Date	Country	Kind
WO2014/141232	9/18/2014	WO	A

US Referenced Citations (456)

Number	Name	Date	Kind
4180613	Vassiliou	Dec 1979	A
4355426	MacGregor	Oct 1982	A
4505767	Quin	Mar 1985	A
4562596	Kornberg	Jan 1986	A
4577631	Kreamer	Mar 1986	A
4617932	Kornberg	Oct 1986	A
4665906	Jervis	May 1987	A
4739762	Palmaz	Apr 1988	A
4787899	Lazarus	Nov 1988	A
4816339	Tu et al.	Mar 1989	A
4878906	Lindemann et al.	Nov 1989	A
4886062	Wiktor	Dec 1989	A
4938740	Melbin	Jul 1990	A
4969458	Wiktor	Nov 1990	A
5042707	Taheri	Aug 1991	A
5064435	Porter	Nov 1991	A
5104404	Wolff	Apr 1992	A
5122136	Guglielmi et al.	Jun 1992	A
5133732	Wiktor	Jul 1992	A
5192286	Phan et al.	Mar 1993	A
5234448	Wholey et al.	Aug 1993	A
5425739	Jessen	Jun 1995	A
5425765	Tiefenbrun et al.	Jun 1995	A
5439446	Barry	Aug 1995	A
5486183	Middleman et al.	Jan 1996	A
5507769	Marin et al.	Apr 1996	A
5509923	Middleman et al.	Apr 1996	A
5522880	Barone et al.	Jun 1996	A
5527322	Klein et al.	Jun 1996	A
5549662	Fordenbacher	Aug 1996	A
5554181	Das	Sep 1996	A
5556413	Lam	Sep 1996	A
5562724	Vorwerk et al.	Oct 1996	A
5575818	Pinchuk	Nov 1996	A
5607445	Summers	Mar 1997	A
5613974	Andreas et al.	Mar 1997	A
5632746	Middleman et al.	May 1997	A
5632763	Glastra	May 1997	A
5632772	Alcime et al.	May 1997	A
5639278	Dereume et al.	Jun 1997	A
5643340	Nunokawa	Jul 1997	A
5653743	Martin	Aug 1997	A
5676696	Marcade	Oct 1997	A
5676697	McDonald	Oct 1997	A
5728134	Barak	Mar 1998	A
5749825	Fischell et al.	May 1998	A
5749879	Middleman et al.	May 1998	A
5755770	Ravenscroft	May 1998	A
5755771	Penn et al.	May 1998	A
5755774	Pinchuk	May 1998	A
5755777	Chuter	May 1998	A
5755781	Jayaraman	May 1998	A
5769882	Fogarty et al.	Jun 1998	A
5769884	Solovay	Jun 1998	A
5782903	Wiktor	Jul 1998	A
5782906	Marshall et al.	Jul 1998	A
5824040	Cox et al.	Oct 1998	A
5827321	Roubin	Oct 1998	A
5843120	Israel et al.	Dec 1998	A
5843170	Ahn	Dec 1998	A
5855600	Alt	Jan 1999	A
5860991	Klein et al.	Jan 1999	A
5876432	Lau et al.	Mar 1999	A
5906641	Thompson et al.	May 1999	A
5921994	Andreas et al.	Jul 1999	A
5944750	Tanner et al.	Aug 1999	A
5976178	Goldsteen et al.	Nov 1999	A
5980552	Pinchasik	Nov 1999	A
6015431	Thornton et al.	Jan 2000	A
6016810	Ravenscroft	Jan 2000	A
6030414	Taheri	Feb 2000	A
6033435	Penn et al.	Mar 2000	A
6036725	Avellanet	Mar 2000	A
6059824	Taheri	May 2000	A
6077298	Tu et al.	Jun 2000	A
6099497	Adams et al.	Aug 2000	A
6117145	Wood et al.	Sep 2000	A
6152956	Pierce	Nov 2000	A
6156064	Chouinard	Dec 2000	A
6168615	Ken et al.	Jan 2001	B1
6200339	Leschinsky et al.	Mar 2001	B1
6206893	Klein et al.	Mar 2001	B1
6270524	Kim	Aug 2001	B1
6283991	Cox et al.	Sep 2001	B1
6290720	Khosravi et al.	Sep 2001	B1
6312458	Golds	Nov 2001	B1
6319287	Frimberger	Nov 2001	B1
6325823	Horzewski et al.	Dec 2001	B1
6344056	Dehdashtian	Feb 2002	B1
6395018	Castaneda	May 2002	B1
6406420	McCarthy	Jun 2002	B1
6428565	Wisselink	Aug 2002	B1
6451048	Berg et al.	Sep 2002	B1
6506211	Skubitz et al.	Jan 2003	B1
6565597	Fearnot et al.	May 2003	B1
6613075	Healy et al.	Sep 2003	B1
6613078	Barone	Sep 2003	B1
6613079	Wolinsky et al.	Sep 2003	B1
6635083	Cheng et al.	Oct 2003	B1
6645242	Quinn	Nov 2003	B1
6648901	Fleischman et al.	Nov 2003	B2
6648911	Sirhan	Nov 2003	B1
6652567	Deaton	Nov 2003	B1
6656214	Fogarty et al.	Dec 2003	B1
6673080	Reynolds et al.	Jan 2004	B2
6692520	Gambale et al.	Feb 2004	B1
6695833	Frantzen	Feb 2004	B1
6730117	Tseng et al.	May 2004	B1
6743195	Zucker	Jun 2004	B2
6748953	Sherry et al.	Jun 2004	B2
6752826	Holloway et al.	Jun 2004	B2
6776794	Hong et al.	Aug 2004	B1
6814749	Cox et al.	Nov 2004	B2
6814752	Chuter	Nov 2004	B1
6824560	Pelton	Nov 2004	B2
6846321	Zucker	Jan 2005	B2
6907285	Denker et al.	Jun 2005	B2
6908477	McGuckin, Jr. et al.	Jun 2005	B2
6929660	Ainsworth et al.	Aug 2005	B1
6942691	Chuter	Sep 2005	B1
6953469	Ryan	Oct 2005	B2
6964679	Marcade et al.	Nov 2005	B1
6986774	Middleman et al.	Jan 2006	B2
7008441	Zucker	Mar 2006	B2
7022131	DeRowe et al.	Apr 2006	B1
7044962	Elliott	May 2006	B2
7083822	Brightbill	Aug 2006	B2
7105020	Greenberg et al.	Sep 2006	B2
7112217	Kugler et al.	Sep 2006	B1
7115127	Lindenbaum et al.	Oct 2006	B2
7122052	Greenhalgh	Oct 2006	B2
7144421	Carpenter et al.	Dec 2006	B2
7175651	Kerr	Feb 2007	B2
7198638	Dong	Apr 2007	B2
7201772	Schwammenthal et al.	Apr 2007	B2
7223266	Lindenbaum et al.	May 2007	B2
7261733	Brown et al.	Aug 2007	B1
7279003	Berra et al.	Oct 2007	B2
7294145	Ward	Nov 2007	B2
7306623	Watson	Dec 2007	B2
7341598	Davidson et al.	Mar 2008	B2
7399313	Brown et al.	Jul 2008	B2
7407509	Greenberg et al.	Aug 2008	B2
7413573	Hartley et al.	Aug 2008	B2
7429269	Schwammenthal et al.	Sep 2008	B2
7442204	Schwammenthal et al.	Oct 2008	B2
7473272	Pryor	Jan 2009	B2
7537609	Davidson et al.	May 2009	B2
7540881	Meyer et al.	Jun 2009	B2
7544160	Gross	Jun 2009	B2
7616997	Kieval et al.	Nov 2009	B2
7632303	Stalker et al.	Dec 2009	B1
7637939	Tischler	Dec 2009	B2
7645298	Hartley et al.	Jan 2010	B2
7655037	Fleming, III et al.	Feb 2010	B2
7662161	Briganti et al.	Feb 2010	B2
7662168	McGuckin, Jr. et al.	Feb 2010	B2
7670369	Schaeffer	Mar 2010	B2
7678141	Greenan et al.	Mar 2010	B2
7708704	Mitelberg	May 2010	B2
7722626	Middleman et al.	May 2010	B2
7731732	Ken	Jun 2010	B2
7803178	Whirley	Sep 2010	B2
7806923	Moloney	Oct 2010	B2
7815673	Bloom et al.	Oct 2010	B2
7833259	Boatman	Nov 2010	B2
7887575	Kujawski	Feb 2011	B2
7914572	Hartley et al.	Mar 2011	B2
7955374	Erickson et al.	Jun 2011	B2
7959662	Erbel et al.	Jun 2011	B2
8016853	Griffen et al.	Sep 2011	B2
8021419	Hartley et al.	Sep 2011	B2
8043365	Thramann	Oct 2011	B2
8048140	Purdy	Nov 2011	B2
8052741	Bruszewski et al.	Nov 2011	B2
8066755	Zacharias	Nov 2011	B2
8080026	Konstantino et al.	Dec 2011	B2
8080053	Satasiya	Dec 2011	B2
8100960	Bruszewski	Jan 2012	B2
8157810	Case et al.	Apr 2012	B2
8157852	Bloom et al.	Apr 2012	B2
8167926	Hartley et al.	May 2012	B2
8172892	Chuter	May 2012	B2
8197475	Bruszewski et al.	Jun 2012	B2
8211158	Wolf	Jul 2012	B2
8216298	Wright et al.	Jul 2012	B2
8221494	Schreck et al.	Jul 2012	B2
8226706	Hartley et al.	Jul 2012	B2
8251963	Chin et al.	Aug 2012	B2
8262719	Erickson et al.	Sep 2012	B2
8273115	Hamer et al.	Sep 2012	B2
8292951	Muzslay	Oct 2012	B2
8333800	Bruszewski et al.	Dec 2012	B2
8353898	Lutze et al.	Jan 2013	B2
8394136	Hartley et al.	Mar 2013	B2
8506622	Bruszewski et al.	Aug 2013	B2
8728148	Roeder et al.	May 2014	B2
8808355	Barrand	Aug 2014	B2
8945203	Shalev et al.	Feb 2015	B2
8968384	Pearson et al.	Mar 2015	B2
9101457	Benary	Aug 2015	B2
9168123	Barrand	Oct 2015	B2
9254209	Shalev	Feb 2016	B2
20010000188	Lenker et al.	Apr 2001	A1
20010004705	Killion	Jun 2001	A1
20010010006	Bachinski et al.	Jul 2001	A1
20010014823	Ressemann et al.	Aug 2001	A1
20010034550	Buirge	Oct 2001	A1
20010044647	Pinchuk et al.	Nov 2001	A1
20010044651	Steinke	Nov 2001	A1
20010044652	Moore	Nov 2001	A1
20010047198	Drasler	Nov 2001	A1
20010049550	Martin et al.	Dec 2001	A1
20010053930	Kugler et al.	Dec 2001	A1
20020040236	Lau	Apr 2002	A1
20020052644	Shaolian et al.	May 2002	A1
20020099441	Dehdashtian	Jul 2002	A1
20020107564	Cox	Aug 2002	A1
20020123791	Harrison	Sep 2002	A1
20020156495	Brenneman et al.	Oct 2002	A1
20020156517	Prouse et al.	Oct 2002	A1
20030040791	Oktay	Feb 2003	A1
20030040804	Stack et al.	Feb 2003	A1
20030057156	Peterson et al.	Mar 2003	A1
20030065345	Weadock	Apr 2003	A1
20030074055	Haverkost	Apr 2003	A1
20030093145	Lawrence-Brown et al.	May 2003	A1
20030114061	Matsuda et al.	Jun 2003	A1
20030130720	DePalma et al.	Jul 2003	A1
20030139802	Wulfman et al.	Jul 2003	A1
20030139805	Holmberg et al.	Jul 2003	A1
20030153944	Phung et al.	Aug 2003	A1
20030153968	Geis et al.	Aug 2003	A1
20030163187	Weber	Aug 2003	A1
20030191523	Hojeibane	Oct 2003	A1
20030199967	Hartley et al.	Oct 2003	A1
20030204236	Letort	Oct 2003	A1
20030204242	Zarins et al.	Oct 2003	A1
20030208192	Truckai et al.	Nov 2003	A1
20030212449	Cox	Nov 2003	A1
20030236567	Elliot	Dec 2003	A1
20040015227	Vardi et al.	Jan 2004	A1
20040015229	Fulkerson	Jan 2004	A1
20040098091	Erbel	May 2004	A1
20040106972	Deaton	Jun 2004	A1
20040106978	Greenberg et al.	Jun 2004	A1
20040117003	Ouriel et al.	Jun 2004	A1
20040133266	Clerc et al.	Jul 2004	A1
20040171978	Shalaby	Sep 2004	A1
20040176832	Hartley et al.	Sep 2004	A1
20040181149	Langlotz et al.	Sep 2004	A1
20040215319	Berra et al.	Oct 2004	A1
20040215320	Machek	Oct 2004	A1
20040215327	Doig et al.	Oct 2004	A1
20050033406	Barnhart et al.	Feb 2005	A1
20050049678	Cocks et al.	Mar 2005	A1
20050065545	Wallace	Mar 2005	A1
20050070995	Zilla et al.	Mar 2005	A1
20050085900	Case	Apr 2005	A1
20050102018	Carpenter et al.	May 2005	A1
20050102021	Osborne	May 2005	A1
20050131512	Vonderwalde	Jun 2005	A1
20050131517	Hartley et al.	Jun 2005	A1
20050143802	Soykan et al.	Jun 2005	A1
20050149166	Schaeffer et al.	Jul 2005	A1
20050154448	Cully	Jul 2005	A1
20050171598	Schaeffer et al.	Aug 2005	A1
20050177132	Lentz et al.	Aug 2005	A1
20050177222	Mead	Aug 2005	A1
20050177228	Solem et al.	Aug 2005	A1
20050203606	VanCamp	Sep 2005	A1
20050216018	Sennett et al.	Sep 2005	A1
20050222649	Capuano	Oct 2005	A1
20050222667	Hunt	Oct 2005	A1
20050222668	Schaeffer et al.	Oct 2005	A1
20050222669	Purdy	Oct 2005	A1
20050234542	Melsheimer	Oct 2005	A1
20050266042	Tseng	Dec 2005	A1
20060015170	Jones et al.	Jan 2006	A1
20060030911	Letort	Feb 2006	A1
20060052799	Middleman et al.	Mar 2006	A1
20060069426	Weinberger	Mar 2006	A1
20060095104	Magers et al.	May 2006	A1
20060095114	Hartley et al.	May 2006	A1
20060100684	Elliott	May 2006	A1
20060106406	Weinberger	May 2006	A1
20060149360	Schwammenthal et al.	Jul 2006	A1
20060155358	LaDuca et al.	Jul 2006	A1
20060155359	Watson	Jul 2006	A1
20060155366	LaDuca et al.	Jul 2006	A1
20060167476	Burdulis, Jr. et al.	Jul 2006	A1
20060173530	Das	Aug 2006	A1
20060178733	Pinchuk et al.	Aug 2006	A1
20060190070	Dieck et al.	Aug 2006	A1
20060193892	Furst et al.	Aug 2006	A1
20060229709	Morris et al.	Oct 2006	A1
20060241740	Vardi et al.	Oct 2006	A1
20060281966	Peacock, III	Dec 2006	A1
20070021822	Boatman	Jan 2007	A1
20070027526	Demetriades et al.	Feb 2007	A1
20070043425	Hartley et al.	Feb 2007	A1
20070050011	Klein	Mar 2007	A1
20070055350	Erickson et al.	Mar 2007	A1
20070055358	Krolik et al.	Mar 2007	A1
20070060989	Deem et al.	Mar 2007	A1
20070061002	Paul, Jr.	Mar 2007	A1
20070067014	Ke et al.	Mar 2007	A1
20070073373	Bonsignore	Mar 2007	A1
20070088425	Schaeffer	Apr 2007	A1
20070106368	Vonderwalde	May 2007	A1
20070112344	Keilman	May 2007	A1
20070135677	Miller et al.	Jun 2007	A1
20070142896	Anderson et al.	Jun 2007	A1
20070150051	Arnault De La Menardiere et al.	Jun 2007	A1
20070156167	Connors et al.	Jul 2007	A1
20070167898	Peters et al.	Jul 2007	A1
20070168018	Amplatz	Jul 2007	A1
20070179598	Duerig	Aug 2007	A1
20070185565	Schwammenthal et al.	Aug 2007	A1
20070208410	Berra et al.	Sep 2007	A1
20070213805	Schaeffer et al.	Sep 2007	A1
20070213807	Roubin	Sep 2007	A1
20070219610	Israel	Sep 2007	A1
20070219614	Hartley	Sep 2007	A1
20070219627	Chu	Sep 2007	A1
20070233229	Berra et al.	Oct 2007	A1
20070237973	Purdy et al.	Oct 2007	A1
20070239256	Weber et al.	Oct 2007	A1
20070244542	Greenan et al.	Oct 2007	A1
20070244543	Mitchell	Oct 2007	A1
20070244547	Greenan	Oct 2007	A1
20070250154	Greenberg	Oct 2007	A1
20070255388	Rudakov et al.	Nov 2007	A1
20080002871	Gunzert-Marx et al.	Jan 2008	A1
20080015673	Chuter	Jan 2008	A1
20080015682	Majercak et al.	Jan 2008	A1
20080033527	Nunez et al.	Feb 2008	A1
20080058918	Watson	Mar 2008	A1
20080064957	Spence	Mar 2008	A1
20080086193	Thramann	Apr 2008	A1
20080109058	Greenberg et al.	May 2008	A1
20080109066	Quinn	May 2008	A1
20080114444	Yu	May 2008	A1
20080114445	Melsheimer et al.	May 2008	A1
20080114446	Hartley et al.	May 2008	A1
20080140178	Rasmussen et al.	Jun 2008	A1
20080147173	McIff et al.	Jun 2008	A1
20080167704	Wright et al.	Jul 2008	A1
20080176271	Silver et al.	Jul 2008	A1
20080195191	Luo	Aug 2008	A1
20080249598	Sherry	Oct 2008	A1
20080262595	Chu et al.	Oct 2008	A1
20080262598	Elmaleh	Oct 2008	A1
20080269789	Eli	Oct 2008	A1
20080275540	Wen	Nov 2008	A1
20080275542	LaDuca et al.	Nov 2008	A1
20080288044	Osborne	Nov 2008	A1
20080294234	Hartley et al.	Nov 2008	A1
20080300665	Lootz	Dec 2008	A1
20080312732	Hartley et al.	Dec 2008	A1
20080319528	Yribarren et al.	Dec 2008	A1
20090012597	Doig et al.	Jan 2009	A1
20090012602	Quadri	Jan 2009	A1
20090030497	Metcalf et al.	Jan 2009	A1
20090030502	Sun et al.	Jan 2009	A1
20090048663	Greenberg	Feb 2009	A1
20090054967	Das	Feb 2009	A1
20090062899	Dang	Mar 2009	A1
20090069881	Chalekian et al.	Mar 2009	A1
20090069882	Venturelli	Mar 2009	A1
20090082841	Zacharias	Mar 2009	A1
20090099640	Weng	Apr 2009	A1
20090099647	Glimsdale et al.	Apr 2009	A1
20090099648	Yu	Apr 2009	A1
20090099649	Chobotov et al.	Apr 2009	A1
20090099650	Bolduc et al.	Apr 2009	A1
20090105809	Lee et al.	Apr 2009	A1
20090112233	Xiao	Apr 2009	A1
20090125096	Chu et al.	May 2009	A1
20090138067	Pinchuk et al.	May 2009	A1
20090149877	Hanson et al.	Jun 2009	A1
20090157014	Osborne et al.	Jun 2009	A1
20090164001	Biggs et al.	Jun 2009	A1
20090171437	Brocker et al.	Jul 2009	A1
20090182270	Nanavati	Jul 2009	A1
20090227997	Wang	Sep 2009	A1
20090240316	Bruszewski	Sep 2009	A1
20090248134	Dierking et al.	Oct 2009	A1
20090254170	Hartley et al.	Oct 2009	A1
20090259290	Bruszewski et al.	Oct 2009	A1
20090287145	Cragg et al.	Nov 2009	A1
20090319022	Hartley et al.	Dec 2009	A1
20100004728	Rao	Jan 2010	A1
20100029608	Finley	Feb 2010	A1
20100057186	West et al.	Mar 2010	A1
20100063575	Shalev	Mar 2010	A1
20100070019	Shalev	Mar 2010	A1
20100082091	Berez	Apr 2010	A1
20100161025	Kuppurathanam et al.	Jun 2010	A1
20100161026	Brocker et al.	Jun 2010	A1
20100161028	Chuter et al.	Jun 2010	A1
20100168838	Hartley et al.	Jul 2010	A1
20100174358	Rabkin et al.	Jul 2010	A1
20100211159	Schmid	Aug 2010	A1
20100249899	Chuter et al.	Sep 2010	A1
20100256725	Rasmussen	Oct 2010	A1
20100268327	Bruszewski et al.	Oct 2010	A1
20100274187	Argentine	Oct 2010	A1
20100274345	Rust	Oct 2010	A1
20100312326	Chuter et al.	Dec 2010	A1
20100318171	Porter	Dec 2010	A1
20100318180	Porter	Dec 2010	A1
20110022149	Cox et al.	Jan 2011	A1
20110022153	Schreck et al.	Jan 2011	A1
20110040366	Goetz et al.	Feb 2011	A1
20110093002	Rucker et al.	Apr 2011	A1
20110125251	Cottone	May 2011	A1
20110152998	Berez et al.	Jun 2011	A1
20110208289	Shalev	Aug 2011	A1
20110208296	Duffy et al.	Aug 2011	A1
20110208297	Tuval et al.	Aug 2011	A1
20110208298	Tuval et al.	Aug 2011	A1
20110218607	Arbefeuille et al.	Sep 2011	A1
20110218609	Chobotov et al.	Sep 2011	A1
20110218617	Nguyen et al.	Sep 2011	A1
20110257720	Peterson et al.	Oct 2011	A1
20110257725	Argentine	Oct 2011	A1
20110262684	Wintsch et al.	Oct 2011	A1
20110264184	Heltai	Oct 2011	A1
20110264192	Hartley et al.	Oct 2011	A1
20110270385	Muzslay	Nov 2011	A1
20110301702	Rust et al.	Dec 2011	A1
20110319983	Zhu et al.	Dec 2011	A1
20120143317	Cam et al.	Jun 2012	A1
20120158038	Leschinsky	Jun 2012	A1
20120172965	Kratzberg	Jul 2012	A1
20120179236	Benary	Jul 2012	A1
20120185031	Ryan et al.	Jul 2012	A1
20120271401	Bruszewski et al.	Oct 2012	A1
20130013050	Shalev et al.	Jan 2013	A1
20130116773	Roeder et al.	May 2013	A1
20130116775	Roeder et al.	May 2013	A1
20130158646	Roeder	Jun 2013	A1
20130197454	Shibata et al.	Aug 2013	A1
20130204311	Kunis	Aug 2013	A1
20130274866	Cox et al.	Oct 2013	A1
20130338753	Geusen	Dec 2013	A1
20140148888	Barrand	May 2014	A1
20140180378	Roeder	Jun 2014	A1
20140316510	Berra	Oct 2014	A1
20140350658	Benary et al.	Nov 2014	A1
20140364930	Strauss et al.	Dec 2014	A1
20150073534	Roeder et al.	Mar 2015	A1
20150196301	Bodewadt et al.	Jul 2015	A1
20150374383	Bodewadt et al.	Dec 2015	A1
20160262880	Li et al.	Sep 2016	A1

Foreign Referenced Citations (103)

Number	Date	Country
2 497 704	Mar 2004	CA
1194577	Sep 1998	CN
1354641	Jun 2002	CN
1748660	Mar 2006	CN
101045022	Oct 2007	CN
201058061	May 2008	CN
101998845	Mar 2011	CN
102 103 055	Sep 2002	DE
0893108	Jan 1999	EP
1 177 779	Feb 2002	EP
1 177 780	Feb 2002	EP
1 325 716	Jul 2003	EP
1759666	Mar 2007	EP
2298248	Mar 2011	EP
2000-279533	Oct 2000	JP
2002-253682	Sep 2002	JP
9639104	Dec 1996	WO
9806355	Feb 1998	WO
9913808	Mar 1999	WO
9925273	May 1999	WO
9934748	Jul 1999	WO
9951165	Oct 1999	WO
0028923	May 2000	WO
0074595	Dec 2000	WO
0076423	Dec 2000	WO
0152776	Jul 2001	WO
02083038	Oct 2002	WO
03034948	May 2003	WO
03099108	Dec 2003	WO
2004017868	Mar 2004	WO
2004045463	Jun 2004	WO
1470797	Oct 2004	WO
2004100836	Nov 2004	WO
2005002466	Jan 2005	WO
2005034809	Apr 2005	WO
2005037138	Apr 2005	WO
2005041781	May 2005	WO
2005041783	May 2005	WO
2005046524	May 2005	WO
2005046526	May 2005	WO
2006007389	Jan 2006	WO
2006028925	Mar 2006	WO
2006036690	Apr 2006	WO
2006070372	Jul 2006	WO
2006088905	Aug 2006	WO
2006130755	Dec 2006	WO
2007084547	Jul 2007	WO
2007115017	Oct 2007	WO
2007144782	Dec 2007	WO
2008008291	Jan 2008	WO
2008021557	Feb 2008	WO
2008035337	Mar 2008	WO
2008042266	Apr 2008	WO
2008047092	Apr 2008	WO
2008047354	Apr 2008	WO
2008051704	May 2008	WO
2008053469	May 2008	WO
2008066923	Jun 2008	WO
2008107885	Sep 2008	WO
2008140796	Nov 2008	WO
2009078010	Jun 2009	WO
2009104000	Aug 2009	WO
2009116041	Sep 2009	WO
2009116042	Sep 2009	WO
2009118733	Oct 2009	WO
2010024869	Mar 2010	WO
2010024879	Mar 2010	WO
2010031060	Mar 2010	WO
2010042210	Apr 2010	WO
2010045238	Apr 2010	WO
2010062355	Jun 2010	WO
2010088776	Aug 2010	WO
2010111583	Sep 2010	WO
2010128162	Nov 2010	WO
2010150208	Dec 2010	WO
2011004374	Jan 2011	WO
2011007354	Jan 2011	WO
2011055364	May 2011	WO
2011064782	Jun 2011	WO
2011067764	Jun 2011	WO
2011070576	Jun 2011	WO
2011080738	Jul 2011	WO
2011095979	Aug 2011	WO
2011100290	Aug 2011	WO
2011106532	Sep 2011	WO
2011106533	Sep 2011	WO
2011106544	Sep 2011	WO
2011116307	Sep 2011	WO
2011136930	Nov 2011	WO
2012039748	Mar 2012	WO
2012104842	Aug 2012	WO
2012176187	Dec 2012	WO
2013005207	Jan 2013	WO
2013030818	Mar 2013	WO
2013030819	Mar 2013	WO
2013065040	May 2013	WO
2013084235	Jun 2013	WO
2013171730	Nov 2013	WO
2014020609	Feb 2014	WO
2014108895	Jul 2014	WO
2014141232	Sep 2014	WO
2014188412	Nov 2014	WO
2015075708	May 2015	WO

Non-Patent Literature Citations (103)

Entry
“E-vita® open plus” product brochure (JOTEC GmbH, Hechingen, Germany), 2010.
Fonseca A et al., “Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions,” J Invasive Cardiol 20(1):21-7 (Jan. 2008).
Khlif H et al., “Contribution to the Improvement of Textile Vascular Prostheses Crimping,” Trends in Applied Sciences Research 6(9):1019-1027 (2011).
An International Search Report dated Sep. 29, 2008, which issued during the prosecution of Applicant's PCT/IL08/000287.
A Written Opinion dated Sep. 29, 2008, which issued during the prosecution of Applicant's PCT/IL08/000287.
An Office Action dated Mar. 28, 2014, which issued during the prosecution of U.S. Appl. No. 13/519,971.
An International Search Report dated Feb. 4, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861.
A Written Opinion dated Feb. 4, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861.
An International Search Report dated Dec. 3, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000564.
A Written Opinion dated Dec. 3, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000564.
An International Search Report dated Nov. 5, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000549.
A Written Opinion dated Nov. 5, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000549.
An International Search Report dated Oct. 6, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000999.
An International Search Report dated Mar. 10, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000917.
An International Search Report dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001018.
An International Search Report dated Apr. 18, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001037.
An International Search Report dated Jul. 7, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001087.
An International Search Report dated Aug. 11, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000135.
An International Search Report dated Jun. 30, 2009, which issued during the prosecution of Applicant's PCT/IL2008/001621.
A Written Opinion dated Jun. 30, 2009, which issued during the prosecution of Applicant's PCT/IL2008/001621.
An International Search Report dated Mar. 11, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312.
A Written Opinion dated Mar. 11, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312.
An English translation of an Office Action dated Aug. 25, 2011, which issued during the prosecution of Chinese Patent Application No. 200880014919.9.
An Office Action dated Nov. 12, 2010, which issued during the prosecution of U.S. Appl. No. 12/447,684.
An Office Action dated Apr. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/447,684.
An Office Action dated Feb. 25, 2013, which issued during the prosecution of U.S. Appl. No. 13/031,871.
An Office Action dated Feb. 27, 2013, which issued during the prosecution of.US Patent Application No. 12/808,037.
An Extended European Search Report dated Dec. 13, 2012, which issued during the prosecution of Applicant's European App No. 08719912.1.
An International Search Report together with Written Opinion both dated Sep. 6, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000190.
An International Search Report together with Written Opinion both dated Aug. 31. 2012, which issued during the prosecution of Applicant's PCT/IL2012/000148.
An Office Action dated Oct. 11, 2012, which issued during the prosecution of U.S. Appl. No. 13/031,871.
An Office Action dated Jun. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/808,037.
An International Search Report together with Written Opinion both dated Sep. 24, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000060.
An International Search Report together with Written Opinion both dated Oct. 1, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000241.
An International Search Report together with Written Opinion both dated Oct. 4, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000269.
An International Search Report together with Written Opinion both dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000300.
U.S. Appl. No. 61/264,861, filed Nov. 30, 2009.
An Office Action dated Jun. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An Office Action dated Feb. 28, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An Interview Summary dated Sep. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An Interview Summary dated Apr. 24, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An Office Action dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
Notice of Allowance dated Oct. 8, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An English Translation of an Office Action dated Jan. 16, 2015, which issued during the prosecution of Chinese Patent Application No. 201080062714.5. (the relevant part only).
An Office Action dated Feb. 5, 2015, which issued during the prosecution of U.S. Appl. No. 13/384,075.
An Office Action dated Feb. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/513,397.
European Search Report dated Feb. 26, 2015, which issued during the prosecution of Applicant's European App No. 12806964.8.
An International Search Report and a Written Opinion both dated Mar. 18, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050973.
An English translation of an Office Action dated Mar. 19, 2015, which issued during the prosecution of Chinese Patent Application No. 201080036970.7.
An Office Action dated Feb. 3, 2015, which issued during the prosecution of U.S. Appl. No. 12/447,684.
Notice of Allowance dated Dec. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/512,778.
An Office Action dated Mar. 26, 2015, which issued during the prosecution of U.S. Appl. No. 13/514,240.
European Search Report dated Mar. 20, 2015, which issued during the prosecution of Applicant's European App No. 08861980.4.
An Office Action dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/240,600.
An Office Action dated Aug. 12, 2015, which issued during the prosecution of U.S. Appl. No. 13/513,397.
An International Search Report and a Written Opinion both dated Jul. 30, 2014, which issued during the prosecution of Applicant's PCT/IL2014/050174.
European Search Report dated Jun. 12, 2014, which issued during the prosecution of Applicant's European App No. 12855964.8.
An Office Action dated Sep. 11, 2015, which issued during the prosecution of U.S. Appl. No. 14/001,641.
An Office Action dated Sep. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/384,075.
An Office Action dated Oct. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/577,161.
An Office Action dated May 15, 2015, which issued during the prosecution of U.S. Appl. No. 13/577,161.
An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/240,600.
European Search Report dated Apr. 22, 2015, which issued during the prosecution of Applicant's European App No. 12828495.7.
An Office Action dated Apr. 14, 2015, which issued during the prosecution of U.S. Appl. No. 14/130,213.
Invitation to Pay Additional Fees dated May 13, 2014, which issued during the prosecution of Applicant's PCT/IL2014/050019.
Invitation to Pay Additional Fees dated May 8, 2014, which issued during the prosecution of Applicant's PCT/IL2014/050174.
An Advisory Action dated Feb. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/807,880.
An Office Action dated Apr. 28, 2014, which issued during the prosecution of U.S. Appl. No. 13/939,798.
An Office Action dated Apr. 24, 2014, which issued during the prosecution of U.S. Appl. No. 13/380,278.
An Office Action dated Apr. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/807,906.
An English translation of an Office Action dated Jan. 28, 2014, which issued during the prosecution of Chinese Patent Application No. 201080036970.7.
European Search Report dated Feb. 17, 2014, which issued during the prosecution of Applicant's European App No. 12803376.
An Office Action dated Jul. 24, 2014, which issued during the prosecution of Canadian Patent Application No. 2,768,228.
European Search Report dated Jan. 18, 2016 which issued during the prosecution of Applicant's European App No. 10799521.9.
European Search Report dated Oct. 27, 2015 which issued during the prosecution of Applicant's European App No. 10835608.0.
An Office Action dated Feb. 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/416,236.
An Office Action dated Mar. 7. 2016, which issued during the prosecution of U.S. Appl. No. 14/240,600.
An Office Action dated Feb. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/241,793.
An Office Action dated Feb. 19, 2016, which issued during the prosecution of U.S. Appl. No. 13/807,880.
An International Search Report and a Written Opinion both dated Feb. 17, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051221.
European Search Report dated Mar. 11, 2016 which issued during the prosecution of Applicant's European App No. 11739497.3.
European Search Report dated Mar. 15, 2016 which issued during the prosecution of Applicant's European App No. 13825456.0.
An Office Action dated Mar. 28, 2016, which issued during the prosecution of U.S. Appl. No. 14/362,194.
Scurr et al., “Fenestrated Aortic Stent Grafts,” Semin Intervent Radiol. Jun. 2007; 24(2): 211-220.
An International Search Report and a Written Opinion both dated Apr. 22, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050049.
Fransen GA, Desgranges P, Laheij RJ, Harris PL, Becquemin JP; EUROSTAR Collaborators. Frequency, predictive factors, and consequences of stent-graft kink following endovascular AAA repair. J Endovasc Ther. Oct. 2003;10(5):913-918.
An Invitation to pay additional fees dated Apr. 12, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050014.
U.S. Appl. No. 61/775,964, filed Mar. 11, 2013.
Extended European Search Report issued in Application No. 10832752.9, dated May 23, 2016.
International Search Report and Written Opinion in PCT/IL2016/05004, dated Jun. 21, 2016.
Office Action issued in related Chinese Application No. 201480026943.X, dated Jun. 30, 2016.
Final Office Action issued U.S. Appl. No. 14/241,793, dated Aug. 3, 2016.
Extended European Search Report issued in related European Application No. 14762507.3, dated Aug. 31, 2016.
Extended European Search Report issued in European Application No. 10834308.8, dated Sep. 22, 2016.
Extended European Search Report issued in European Application No. 14801036.6, dated Oct. 27, 2016.
Non-Final Office Action issued in U.S. Appl. No. 14/240,600, dated Nov. 2, 2016.
Notice of Allowance issued in U.S. Appl. No. 14/362,194, dated Nov. 10, 2016.
Office Action issued in Chinese Application No. 201510685240.4, dated Dec. 27, 2016.
Non-Final Office Action issued in U.S. Appl. No. 14/518,542, dated Jan. 12, 2017.
Patrick O'Gara, M.D., Aortic Aneurysm, Circulation, 2003.
Second Office Action issued in Chinese Application No. 201480012648.9, dated Jul. 22, 2016.
Non-Final Office Action issued in U.S. Appl. No. 14/400,699, dated Dec. 7, 2016.

Related Publications (1)

	Number	Date	Country
	20160030209 A1	Feb 2016	US

Provisional Applications (1)

	Number	Date	Country
	61775964	Mar 2013	US

Multi-component stent-graft system for aortic dissections

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

US

International Classifications

Term Extension

Abstract

Description

Claims

CROSS-REFERENCE TO RELATED APPLICATION

PCT Information

US Referenced Citations (456)

Foreign Referenced Citations (103)

Non-Patent Literature Citations (103)

Related Publications (1)

Provisional Applications (1)